Podcasts about eeg

Germany's utility-scale battery deployment is hitting an inflection point. After years of projects piling up in development pipelines, utility-scale storage is arriving at gigawatt scale – just as Germany's huge solar fleet drives electricity prices towards zero, or below, during sunny hours. For batteries that can shift that power into higher-priced periods, the opportunity is enormous. Host Jonathan Gifford speaks with Thaddäus Kreisig, Principal at Aurora Energy Research, about Germany's forming battery boom – and how developers are building revenue stacks to make projects viable. The shift is striking: more than two-thirds of solar developers recently surveyed by Aurora said every project they plan to deploy will be co-located with a battery system. Falling battery-system equipment costs are strengthening the business case, while arbitrage, ancillary services, EEG revenues, and new financing models are opening up ways in which battery energy storage systems can pay off. But grid constraints remain a major hurdle. Flexible connection agreements can restrict when batteries charge and discharge – limiting revenues, even as energy storage could help resolve the German energy market's pricing peaks and troughs. In short, Germany's massive solar fleet has created both the need and the opportunity for batteries. And energy storage is rapidly shifting from optional extra to essential infrastructure – but the route-to-market for projects certainly promises to be an interesting ride. ✉️ Questions, comments or suggestions? Reach us at podcast@thesmartere.com

With over a decade of clinical experience as a chiropractor specializing in neurology, Dr. Trevor Colm has worked extensively with patients across a broad spectrum of neurological and autonomic conditions. His clinical career has been defined by a relentless focus on understanding and objectively measuring brain function in real time.Over the past five years, Dr. Colm has led the development of Cortex, the world's first fully robotic EEG system. Designed to eliminate the complexity and limitations of traditional neurodiagnostics, Cortex deploys in just five seconds, processes data through multiple advanced algorithms, and delivers real-time neurological insights through an intuitive, modern interface.By merging clinical neuroscience, robotics, and advanced data processing, Dr. Colm is pioneering a new standard for scalable, real-time brain assessment—bringing objective brain metrics out of the lab and into everyday clinical practice.Webiste: www.cortexbrain.com

Your body will tell you when you're too hot, too hungry, or too tired. But no one tells you can't feel the load your environment puts on your body, which is exactly why it's easy to ignore.Today I talked to Philipp Samor von Holtzendorff-Fehling, founder of Leela Quantum Tech and a former T-Mobile executive, known for spending six years and more than 40 placebo-controlled trials building a case that the biofield is something you can measure and support. We unpack what he says shows up on brain scans during a 5G call, the studies behind his claims, and which everyday exposures he thinks matter most.He isn't selling fear or a magic bullet, and he leaves you with practical takeaways you can act on this week without buying a thing.What we explore:- EMF exposure: what a 256-channel EEG picks up seconds into a 5G call- Electric cars and electronics: the exposure you can't opt out of, and what to do instead- Blue light and sunlight: why he ranks them above food as a daily stressor- Biofield research: ATP production, wound healing, and what the studies actually measured- The two-minute check-in: the free daily practice he says matters mostChapters:00:00 From Telecom Executive to Energy Work04:33 Why Men Struggle to Trust Their Intuition14:55 Why He Started Leela Quantum Tech19:10 Why He Ran 40 Placebo Controlled Trials24:20 What an EEG Shows During a 5G Call34:38 Are Electric Cars Frying Your Body?40:36 Dog Study Results: Better Blood, Less Anxiety46:29 How Stress and EMFs Affect Fertility52:46 Blue Light or EMF: Which Is Worse?59:01 How to Protect Kids From Screens and EMFs01:13:09 The 2 Minute Morning and Night Check InAbout Philipp Samor von Holtzendorff-Fehling: Philipp Samor von Holtzendorff-Fehling is the founder and CEO of Leela Quantum Tech and Quantum Upgrade. He spent over two decades as an international business executive, including a stint as Vice President at T-Mobile, while training privately in shamanic and other energy healing practices. He's also a Kundalini yoga teacher and a nationally ranked senior tennis player.Connect with Philipp Samor von Holtzendorff-Fehling: Website: https://leelaq.comInstagram: https://www.instagram.com/philipp_vhf/–The Gabby Reece ShowThis is where I have real conversations with the people I find most worth listening to: scientists, athletes, coaches, parents, and thinkers who are doing the hard work of building a life that holds up over time. No hacks. No quick fixes. Just honest, practical conversations about performance, longevity, relationships, and what it actually takes to show up well at every age.If you are here, you probably already know that health is not a destination. It is how you live. I am glad you are along for it.Connect with Gabby Reece:Instagram: https://www.instagram.com/gabbyreece/TikTok: https://www.tiktok.com/@gabbyreeceofficialWebsite: https://gabriellereece.com This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit thegabbyreeceshow.substack.com

For over a century, organisations have relied on a rigid, factory-inspired model of how we think. We assume that every worker operates on a standard cognitive rhythm, thriving under the same conditions of open-plan offices, back-to-back meetings, and eight-hour shifts. These organizational habits were born of convenience, not science. We are currently designing our entire professional lives around assumptions that lack any grounding in neuroscience. The reality is that the brain is the most complex system known to humanity, holding roughly 86 billion neurons and trillions of neural connections. While leaders and managers continue to force employees into uniform boxes, the rapid rise of Artificial Intelligence is quietly shifting the cognitive landscape. We are operating in a gap where the decision-makers behind our work structures often possess little understanding of the cognitive biology they govern.Ofer, as a technologist who has spent a decade applying neurofeedback to the human mind, recognises that treating the brain like a computer is a fundamental error. If we want people to flourish rather than just perform, we must move away from the obsession with standardisation and start respecting the individual architecture of the human mind and the fact that this can look different in different people.We are currently also seeing a decline in global attention spans. The average human attention window online is now just 2.8 seconds. When you land on a page, you have less time to capture a user's attention than a goldfish.Ofer developed neurofeedback technology to bridge the gap between clinical needs and personal development. By using EEG sensors to track brain wave activity, individuals can receive real-time, visual, and auditory feedback on their focus levels. In practice, this looks like a game where the user serves as the pilot of a digital vehicle, controlling its movement through focus alone. When the user becomes distracted, the feedback loop prompts them to return to a state of engagement.This process steps outside the traditional box of corporate and educational uniformity. By treating attention as a skill to be trained rather than a fixed personality trait, we move toward a model of individual development. This is particularly relevant for those diagnosed with ADHD, as it offers a way to strengthen prefrontal cortex activity—the area often associated with sustained focus. The effectiveness of this method stems from its millisecond-long feedback loop, which is far more potent than the annual performance reviews we rely on in traditional management.By providing a way to measure and improve cognitive state, this technology empowers users to take ownership of their own mental performance. It demonstrates that we are not locked into our current cognitive limitations. With the right tools, we can train our attention mechanisms to handle the complexities of a distracted, high-tech world, ultimately fostering a higher degree of agency and self-mastery in our work lives.As AI integrates further into our workflows, the value of the human “edge”—our ability to think critically, connect dots, and navigate ambiguity—will only increase. Leaders should be wary of over-automating processes that require human nuance. The goal should be to use machines to handle the rote tasks so humans can flourish in roles that require empathy, creativity, and high-level judgment.The strategy for the future isn't more software or faster tools, it's about building “flexible structures” that accommodate different thinking styles. We must hold our management theories with humility and pivot from a culture of constant, fragmented attention to one that values deliberate, focused, and human-centric interaction. Whether through neurofeedback, better meeting design, or simply setting our phones aside to listen to one another, small changes can yield significant cognitive benefits. The path toward organisational health requires us to accept that our differences are not problems to be solved, but assets to be utilized. As we look ahead, let us commit to building environments that nourish the brain rather than exhausting it.Are your current team rituals helping your people think, or are they just keeping them busy? It's time to move from managing output to supporting human flourishing.The main insights you'll get from this episode are : The human brain is the most complex system known in the universe - we don't know how a neuron works and neither do we understand consciousness.It functions in a totally different way from a silicon-based computer; no computer can truly understand, only process large-scale mathematics/data.Unlike AI, the human brain has taken millennia to evolve and only consumes 20W of energy – this evolution produces an optimised system.Is AI conscious? No computer is conscious, and intelligence requires understanding, which we also do not fully comprehend.We can learn more easily than we can unlearn: learning is repetition to create new neural pathways.The brain-computer interface based on electromagnetic brainwave frequencies produces neurofeedback, i.e. feedback in real time to teach something new.Brain training for the third age is aimed at retaining cognitive performance.Companies are built by people and thrive on the connections between them therefore it is advisable to adapt rules to different people/brains.AI produces amazing results in certain (scientific) fields but has a very negative impact on the population at large who have no need to think or learn.Education systems are not evolving and still based on the ‘banking' system whereby the teacher deposits information into students' mind.Project-based learning is proven to be more effective - it introduces the element of experience and is interesting.The human hippocampus is shrinking, which is a very scary prospect for the future and those who will be the leaders.The western world is organised around efficiency, which does not equate to human flourishing.Making neurofeedback accessible, affordable, and feasible is a gamechanger to help people increase their attention.Attention is a competitive advantage these days and hijacking it is very destructive, with fragmented attention often described as ‘busy'.Preventive measures include paying attention to our lack of attention, practicing more and managing our time correctly - the brain is not a multitasker by design.Find out more about Ofer and his work here :https://excellent-brain.com/https://www.linkedin.com/in/oferlidsky/For more information on this episode please visit www.transformforvalue.com/podcastTo carry on developing your leadership and building a relevant & high performing team, connect with me here : https://calendly.com/transformforvalue/connect

Broadcast from KSQD, Santa Cruz on 9-10-2026: The Pennsylvania measles outbreak has reached 540 confirmed cases with 119 new cases in the past week—the highest yearly count in 35 years, with likely three-fold undercount. Dr. Dawn emphasizes measles' R-value of 14 (versus COVID's peak of 3), its four-day pre-rash contagion window, and two-hour airborne persistence. Lancaster County's pediatric vaccination has dropped from the 95% threshold needed for herd immunity to 87%. She discusses the recent infant death (measles at birth with subsequent splenic rupture during vaginal delivery), the impossibility of vaccinating pregnant women against this live-virus disease, and public health workers doing pop-up clinics and home vaccine delivery. Dr. Dawn criticizes federal threats to strip tax-exempt status and terminate federal grants from universities like UCLA and UC Davis over race-conscious admissions. She argues this targets exactly the schools admitting students most likely to serve underserved communities and enter primary care—where the physician shortage is most acute—rather than dermatology or interventional radiology at tertiary centers. UCLA's Eisenberger social pain lab found that social exclusion (via a rigged game with undergraduates) activates the same brain regions as physical pain (dorsal anterior cingulate cortex and anterior insula on fMRI). A follow-up study showed acetaminophen blunted both self-reported social pain and empathy for others' pain, later replicated with EEG changes in DACC. Dr. Dawn suggests strategic use before stressful social events—though not combined with alcohol. Orexins are wakefulness-regulating neurotransmitters discovered in narcoleptic Doberman Pinschers and Labrador Retrievers. Takeda's oveporexton was approved August 5 as the first orexin agonist for narcolepsy, and Eli Lilly recently paid $8 billion for a related biotech, with Morgan Stanley projecting $16 billion in annual sales. Beyond narcolepsy, orexin agonists show promise for ADHD, attention/motivation, and potentially sleep apnea, with lower abuse potential than methylphenidate or Adderall. A caller advocates for free education and mandatory multilingual instruction in elementary school. Dr. Dawn describes France's tuition-and-food-subsidized medical education with post-graduation community service requirements built in, and shares her own experience with 2% National Defense Student Loans established after Sputnik. Researchers identified a distinctive brain-wave signature marking the transition to unconsciousness under propofol anesthesia—the loss of alpha-band coordination between the parietal cortex and thalamus. Delivered via scalp electrodes, this signature could enable individualized anesthesia dosing and provide non-behavioral markers of consciousness for brain-injured patients. A grandmother caller asks about protecting her first-grader during the measles outbreak. Dr. Dawn confirms two-dose MMR vaccination provides 100% protection against severe measles and 98% against mild disease, and reminds her to prompt women of childbearing age to verify their vaccination status before pregnancy, since maternal measles or COVID infection carries much higher mortality. Researchers studying breath and stool volatile compounds in asthmatic children identified four molecular markers that could enable early sepsis detection through breath analysis. This would prove especially valuable in neonates, where blood cultures are technically difficult, and could provide hours-to-days warning before clinical sepsis manifests. Vaginal birth exposes the infant to maternal vaginal and fecal bacteria that serve as the first beneficial inoculation, with some maternal microbes crossing the placenta prenatally. During the first week of life, maternal antibodies in colostrum and breast milk train the neonatal immune system to tolerate friendly bacteria—preventing later asthma, food allergies, and autoimmune disease. Dr. Dawn highlights colostrum as the critical component and suggests it should be sourced for infants who cannot be breastfed. Magnesium L-threonate crosses the blood-brain barrier efficiently, with about a gram at bedtime improving deep and REM sleep, morning alertness, mood, and productivity. It also reduces migraine severity, and one of Dr. Dawn's patients successfully replaced ADD medications with 3g daily. The only meaningful upper limit is diarrhea, which signals malabsorption.

Neurofeedback pioneer Joy Lunt, RN opens this classic NeuroNoodle Open Mic conversation with a case that still grabs your attention: a client with dissociative identity disorder whose EEG "utterly changed" mid-session—"like as if somebody else was sitting in the chair." Later, Joy describes seeing the EEG of one personality look like that of a four-year-old child.This is NeuroNoodle before today's Brain Bar—the audience-driven Open Mic format where Pete Jansons brought viewer questions directly to the panel. Joy Lunt, Jay Gunkelman, Dr. Mari Swingle, Dr. Andrew Hill, John Mekrut, Joshua Moore, Anthony Ramos and the crew move from DID and EEG patterns into depression and the salience network, neurofeedback protocols, Joy's striking experience using neurofeedback with her mother after a Parkinson's diagnosis, Parkinson's and repeated head trauma, the panel's debate over "digital Ozempic" and the brain, insomnia, exhausted kids, autism, and why hyperfocus and flow are "not even close."

A disputed set of bog photos out of upstate New York has Bigfoot researchers split between a juvenile Sasquatch and a very cold, very unlucky hiker. In western Pennsylvania, longtime cryptid investigator Stan Gordon logged two more encounters on back-to-back days, one involving a torso rotation witnesses describe as unnaturally mechanical. Also this week: a troop of chimpanzees has been throwing rocks at the same handful of trees for more than a decade, and nobody studying them has a confirmed explanation why.Nearly a mile beneath South Dakota, the LUX-ZEPLIN detector recorded what a twenty-year veteran of dark matter research is calling the most interesting single event of his career. The result carries less than a one percent chance of being ordinary background noise, and the team still won't say the word "discovery." It may be the first real trace of dark matter ever directly recorded. It may also just fade away.A two-year study out of the University of Liège just broke one of the oldest assumptions in near-death research. Neuroscientist Charlotte Marshall's team wired 180 ICU patients with EEG equipment and captured twelve near-death experiences happening in real time, not reconstructed afterward from memory. The brains of those patients weren't shutting down; they showed more neural complexity than a normal, awake brain does. It's part of why a new survey now puts the number of Americans reporting a near-death experience at over sixty million.Jeremy's Book: https://www.amazon.com/U-F-Elmwood-Cosmic-Puzzle/dp/B0GX1GBMZNYouTube: https://www.youtube.com/@InfiniteRabbitHolePodcastWebsite: https://InfiniteRabbitHole.com

Raw Garlic "Ultimate Biohack" Trend Faces Scientific Scrutiny Raw garlic has gone viral as a morning ritual, with fans crushing a clove, mixing it with honey, and crediting it with everything from lower cholesterol and better insulin sensitivity to cleared acne, eliminated brain fog, and colds cured within 24 hours. The biochemistry behind the trend is real: garlic contains no allicin until it's crushed or chopped, which mixes an enzyme with a sulfur compound to form the active compound, and letting it sit for ten to fifteen minutes before cooking preserves more of that activity. Host Dave Asprey separates what the human data actually supports, modest blood pressure and cholesterol effects, real antimicrobial properties, and a genuine bleeding-risk caution for anyone on blood thinners, from the unproven parasite-cleanse and brain fog claims driving the trend online, drawing on his own EEG tracking to challenge the cognitive benefit narrative directly. Sources: https://nypost.com/2026/09/01/health/is-garlic-the-ultimate-biohack/ https://holisticheartcenters.com/new-cholesterol-guidelines-2026/ ~~ HEPA Air Filtration Linked To Measurable Brain Function Improvements In One Month A new study found that older adults using true HEPA filtration to reduce indoor fine particulate matter saw small but measurable cognitive improvements after just one month, adding to a growing body of evidence connecting air pollution exposure to neuroinflammation and long-term cognitive decline. Host Dave Asprey breaks down why clean air belongs in the biohacking conversation alongside supplements and training protocols, and why the World Health Organization's decision to list air pollution as a modifiable dementia risk factor is a bigger deal than it sounds. Sources: https://www.sciencedaily.com/releases/2026/08/260830000016.htm https://health.yahoo.com/conditions/neurological/dementia/articles/7-dementia-risk-factors-revealed-110006268.html ~~ Egg Yolk-Derived Peptides Show Neuroprotective Effects Against Oxidative Stress New research on phosphopeptides isolated from egg yolk phosvitin found that the compounds reduced reactive oxygen species, improved antioxidant defense markers, and increased neuron survival in cells exposed to oxidative stress in the lab. Host Dave Asprey connects this early but promising finding to his long-standing case for the whole egg, yolk included, as one of the most nutrient-dense foods available, and flags what would need to happen next for this to translate into a usable protocol. Source: https://www.news-medical.net/news/20260827/Egg-yolk-peptides-protect-brain-cells-from-oxidative-stress.aspx ~~ Heat Stroke Survivors Face Elevated Cardiovascular Risk Years Later, Research Shows A closer look at heat stroke recovery reveals it's rarely a one-day event. Survivors of classic heat stroke had three and a half times the rate of ischemic heart disease twelve years later compared to matched controls, along with elevated long-term risk of kidney disease and lingering heat intolerance, fatigue, and dizziness. Host Dave Asprey draws the line between the controlled heat stress he uses deliberately in sauna and hyperthermic conditioning and the uncontrolled, uncooled heat exposure that leaves this kind of lasting cardiovascular damage, and what that distinction means for how to think about any stressor. Source: https://www.latimes.com/science/story/2026-09-01/even-people-who-appear-to-recover-from-heatstroke-may-face-health-issues-later ~~ Long-Term Melatonin Use Linked To Nearly Double Heart Failure Risk In Large Cohort Study A cohort study of over 130,000 adults with chronic insomnia found that those who used melatonin for a year or more had nearly double the rate of heart failure and all-cause mortality compared to non-users, along with a three and a half times higher rate of heart failure hospitalization. Host Dave Asprey walks through why this is observational data, not proof of causation, and why he's stayed a low-dose, occasional melatonin user for years rather than a nightly one, plus what the real underlying driver of chronic insomnia might be for listeners still relying on it every night. Source: https://www.sciencedaily.com/releases/2026/08/260829035228.htm ~~ This episode is designed for biohackers, longevity enthusiasts, and high-performance listeners who want the latest research on nutrition, air quality, brain health, heat stress, and sleep translated into what actually matters for your biology right now. Host Dave Asprey connects viral trends, clinical data, and decades of context into practical frameworks for taking control of your own health decisions. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: raw garlic biohack, allicin formation, garlic blood pressure, aged garlic extract, garlic cholesterol, HEPA air purifier brain health, PM2.5 cognitive decline, air pollution dementia risk, egg yolk phosvitin peptides, oxidative stress neuroprotection, egg yolk nutrition, heat stroke cardiovascular risk, heat stroke recovery, hyperthermic conditioning, sauna protocol, melatonin heart failure risk, chronic insomnia, sleep hygiene, circadian rhythm, biohacking news 2026 Thank you to our sponsors! Beyond Wonderland Conference | Oct 13 - 14, 2026. Get your ticket now at wonderlandconference.comKenetik | Instead of pushing your system harder, Kenetik feeds your brain the ketones it craves to fuel calm clarity and steady focus. Go to drinkkenetik.com/DAVE and use code DAVE for a discount.iRestore | Unlock your best hair & skin with @iRestorelaser and HUGE savings on iRESTORE with code DAVE at irestore.com/DAVEResources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Intro 00:19 – Garlic & Brain Fog 02:06 – HEPA Filtration & Cognition 03:20 – Egg Yolk Peptides04:16 – Heat Stroke05:22 – Melatonin06:54 - WrapupSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jay Gunkelman has read more than half a million brain scans - and in this Carnac session he and host Pete Jansons put one of the hardest cases on the table: a four-and-a-half-year-old, nonverbal, what most people would bluntly call "full autism." On paper it looks hopeless. Jay's blind read shows a brain running like a six-month-old's - no background alpha, diffuse slowing, and a sharp-slow focus buried in the left-temporal language area. Then comes the part nobody expects: in the research Jay cites, 70% of autistic clients show epileptiform activity on EEG - and 85% when you record a full 24 hours including sleep. Dr. Mari Swingle joins to turn the squiggles into a plan - where to start, why sensory integration has to come before language, and why she underlines the word "yet." The bigger surprise is the prognosis: Jay has watched kids exactly like this "come out of the diagnostic categorization entirely" and pass for neurotypical. It's not a cure, and it's not a shot or a pill - it's 40 to 100+ sessions, parents on board, and a long-term relationship. As Jay puts it: it's not magic, it's neuroscience.

The late Peter Fenwick, PhD, is coauthor with his wife, Elizabeth, of The Truth in the Light, The Art of Dying, The Hidden Door: Understanding and Controlling Your Dreams, and Past-Lives: An Investigation Into Reincarnation Memories. He is also author of Shining Light on Transcendence: The Unconventional Journey of a Neuroscientist. He is President Emeritus of the Scientific and Medical Network. In this video, rebooted from 2021, he describes his research in a variety of areas including epilepsy, near-death experience, deathbed experiences, and the dying process itself. He also describes unusual research on the process of "giving light" associated with a spiritual teacher named Alain Forget. EEG measurements during this process were suggestive of brain to brain communication. New Thinking Allowed host, Jeffrey Mishlove, PhD, is author of The Roots of Consciousness, Psi Development Systems, and The PK Man. Between 1986 and 2002 he hosted and co-produced the original Thinking Allowed public television series. He is the recipient of the only doctoral diploma in "parapsychology" ever awarded by an accredited university (University of California, Berkeley, 1980). He is also the Grand Prize winner of the 2021 Bigelow Institute essay competition regarding the best evidence for survival of human consciousness after permanent bodily death. He is Co-Director of Parapsychology Education at the California Institute for Human Science. (Recorded on March 4, 2021) For a complete, updated list with links to all of our videos, see https://newthinkingallowed.com/Listings.htm. Check out the New Thinking Allowed Foundation website at http://www.newthinkingallowed.org. There you will find our incredible, searchable database as well as opportunities to shop and to support our video productions – plus, this is where people can subscribe to our FREE, weekly Newsletter and can download a FREE .pdf copy of our quarterly magazine. To order high-quality, printed copies of our quarterly magazine: NTA-Magazine.MagCloud.com Check out New Thinking Allowed's AI chatbot. You can create a free account at awakin.ai/open/jeffreymishlove. When you enter the space, you will see that our chatbot is one of several you can interact with. While it is still a work in progress, it has been trained on 1,600 NTA transcripts. It can provide intelligent answers about the contents of our interviews. It's almost like having a conversation with Jeffrey Mishlove. If you would like to join our team of volunteers, helping to promote the New Thinking Allowed YouTube channel on social media, editing and translating videos, creating short video trailers based on our interviews, helping to upgrade our website, or contributing in other ways (we may not even have thought of), please send an email to friends@newthinkingallowed.com. To download and listen to audio versions of the New Thinking Allowed videos, please visit our new podcast at https://itunes.apple.com/us/podcast/new-thinking-allowed-audio-podcast/id1435178031. Download and read Jeffrey Mishlove's Grand Prize essay in the Bigelow Institute competition, Beyond the Brain: The Survival of Human Consciousness After Permanent Bodily Death, go to https://www.bigelowinstitute.org/docs/1st.pdf. You can help support our video productions while enjoying a good book. To order a copy of New Thinking Allowed Dialogues: Is There Life After Death? click on https://amzn.to/3LzLA7Y (As an Amazon Associate we earn from qualifying purchases.) To order the second book in the New Thinking Allowed Dialogues series, Russell Targ: Ninety Years of ESP, Remote Viewing, and Timeless Awareness, go to https://amzn.to/4aw2iyr To order a copy of New Thinking Allowed Dialogues: UFOs and UAP – Are We Really Alone?, go to https://amzn.to/3Y0VOVh To order a copy of Charles T. Tart: Seventy Years of Exploring Consciousness and Parapsychology, go to https://amzn.to/4oOUJLn

September 2, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Scan.com raises $220M to expand its medical imaging network, connecting patients and providers through a single API in a $100B+ US market still run by phone and fax Atlas opens pre-orders for a $499 behind-the-ear EEG wearable tracking presence, stress, and energy burn using over 500,000 real-life brain recordings Dyson launches the $499 CameraJet toothbrush, using a built-in camera and AI to identify gaps in real time and fire precision mouthrinse More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe  Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider  Reach out → insider@fitt.co

Send us Fan MailS6 143 - Do Sleep Trackers Really Know How You Slept? Oura Ring, Apple Watch & the ScienceDo your Oura Ring, Apple Watch, Fitbit, or Garmin actually know when you're asleep, or are they making an educated guess?In this episode of Sleep Takeout, psychologist Dr. Daniel Baughn and sleep medicine physician Dr. Michelle Zetoony break down what sleep trackers really measure, how those measurements compare with a clinical sleep study, and why your nightly sleep score may not be as precise as it looks.We also examine the proposed class action lawsuit involving Oura's sleep-stage accuracy claims, what Oura says in response, and what the research actually tells us about consumer sleep wearables.You'll learn:

What would mental healthcare look like if we focused less on diagnostic categories and more on understanding how an individual's brain is functioning?Jeffrey Schutz, MA, LMFT, BCN, joins Dr. Saul Rosenthal to discuss what he sees as a shift toward brain-based mental healthcare. They explore how neurofeedback and QEEG can change the way clinicians think about assessment, symptoms, and treatment planning, while also considering the limitations of EEG data and the risks of overinterpretation.Jeff and Saul also discuss the importance of clinical judgment in an era of increasingly automated and AI-driven neurofeedback systems, what Jeff has learned from building a large multidisciplinary neurofeedback practice, and the challenges of making neurofeedback affordable and accessible through insurance.Jeffrey Schutz is the founder and executive director of The Neurovation Center in Connecticut, author of Launching Your Career in Neurofeedback: The Definitive Guidebook, and President-Elect of the Northeast Region Biofeedback Society.Jeff will present “Pioneering the Brain-Based Frontier: Innovative Strategies for Integrating Neurofeedback into a Mental Health Setting” at the 2026 NRBS Annual Conference.This interview previews the 2026 Northeast Region Biofeedback Society Annual Conference, held virtually September 26–27. Go to NRBS 2026 Conference before the early-bird deadline and use code NRBS26INVITE for an additional 10% discount.Contact us at healthybrain@nrbs.org.Subscribe here or wherever you get your podcasts.Watch the video versions of our podcasts and Subscribe there as well!This podcast is produced by the Northeast Region Biofeedback Society. NRBS is an organization for professionals, students, and everyone interested in neurofeedback, biofeedback, and whole body health.Learn more about Dr. Saul Rosenthal at advancedbehavioral.care.Our theme music is Catch It by Coma-MediaThe Healthy Brain Happy Body logo was designed by Alexandra VanDerlyke. Our heartfelt thanks to her and the rest of the team at Collectively Rooted.#Neurofeedback #Biofeedback #Migraine #MentalHealth #BrainHealth #PIRHEG #HEG #PainManagement #EmotionalPain #Seizures #PrefrontalCortex #PsychologyPodcast #ClinicalPsychology #MindBodyConnection #Neuroscience #Therapists #Counselors #BrainBasedTherapy #NRBS #HealthyBrainHealthyBody

Dr. Jim Wilder has been thinking about the relationship between brain science and spiritual formation since before most people knew the question existed. He trained under one of the inventors of the EEG machine, spent years working alongside Dallas Willard, and has spent decades building what he calls the Life Model — a unified account of what it looks like to grow up into the likeness of Christ, neurologically and spiritually. This conversation is an hour inside that work.Michael and Jim talk about why the right brain runs faster than the conscious mind — and what that means for every Christian who has tried to think their way into a changed life. They talk about why joy isn't a rare gift but the baseline the brain was designed to run on, and what happens when it isn't. They discuss identity, shame, and what it means for the brain to perceive itself only through how other people see us. And Jim tells the story of a professor who looked at a kid who couldn't spell and said, "You might want to consider being a writer." Eighteen books later, that moment still explains everything.Support the showENGAGE THE RESTORING THE SOUL PODCAST:- Follow us on YouTube - Tweet us at @michaeljcusick and @PodcastRTS- Like us on Facebook- Follow us on Instagram & Twitter- Follow Michael on Twitter- Email us at info@restoringthesoul.com Thanks for listening!

Sunday, August 30, 2026 — Week 36 TRIALS & DATA — CAMP4, RARE-X + ProMMiS CAMP4 / CMP-002 Australia and Argentina cleared. EU and UK filings underway. First-in-human Phase 1/2 study still targeted for Q4 2026. CMP-002 is designed to increase expression of the healthy SYNGAP1 copy. CAMP4 raised another $50M and reports cash runway through the end of 2028. Q2 earnings / corporate update: https://investors.camp4tx.com/news-releases/news-release-details/camp4-reports-second-quarter-2026-financial-results-and Rare-X + ProMMiS Rare-X is our PRO partner for the ProMMiS Natural History Study. IMPORTANT: Families participating in ProMMiS need to complete their Rare-X surveys within SEVEN DAYS of their ProMMiS Natural History Study visit date. We need the patient/caregiver-reported data to line up with the clinical visit data. ProMMiS: https://curesyngap1.org/resources/studies/syngap1-prommis/ Rare-X: https://cureSYNGAP1.org/RAREX  ARI WEBINAR If you missed the Ari webinar, the recording is now available. https://cureSYNGAP1.org/AriWeb  FUNDRAISE WITH US Please call us to set up your fundraisers.  Please do not use Facebook fundraising unless it's an emergency. CURE SYNGAP1 ON THE ROAD — BRAIN FOUNDATION Kathryn and I are attending the BRAIN Foundation's Synchrony 2026 scientific summit in Palo Alto. A chance for CURE SYNGAP1 to stay close to work happening across autism, neurology, genetics, biomarkers and therapeutics. https://brainfoundation.org/synchrony-symposia/ ILAE — EUROPEAN EPILEPSY CONGRESS Virginie is heading to Athens for the 16th European Epilepsy Congress, September 5–9. If you are going to be at the ILAE meeting in Athens, Greece, reach out to Virginie and connect with CURE SYNGAP1 in person. https://www.ilae.org/eec2026 UPCOMING EVENTS — COUNTDOWN SCRAMBLE FOR SYNGAP — 34 DAYS October 3 — Greer, South Carolina 5th Annual Scramble for Syngap https://cureSYNGAP1.org/Scramble SHOOT FOR SYNGAP1 — 76 DAYS November 14 — Hurricane, Utah Aiming for a Cure — Shooting for Hope https://cureSYNGAP1.org/Shoot FIGHT FOR FELIPE — 90 DAYS November 28 — Boston, Massachusetts https://cureSYNGAP1.org/Fight CURE SYNGAP1 CONFERENCE — 95 DAYS December 3–4 — Denver, Colorado Early bird pricing ends August 31! https://cureSYNGAP1.org/Reg26 PUBMED PubMed 2026 is at 49. +2 since Episode 214. +13 vs. the week. Last year finished at 61, +9 vs. the year. https://pubmed.ncbi.nlm.nih.gov/?term=syngap1&filter=years.2026-2026&sort=date Coolest new paper: TBE on EEG.  https://pubmed.ncbi.nlm.nih.gov/42620081/  USA

Jay Gunkelman has read more than half a million brain scans — and this week host Pete Jansons handed him one he refused to read. Working through the recording, Jay's verdict wasn't a diagnosis or an interpretation. It was simpler: "This isn't real. Do it again."That kicks off a conversation with Jay and Dr. Mari Swingle about the thing that gets lost in all the excitement over brain maps: the interpretation is only as good as the recording underneath it. From the minimum standards most people skip, to the craft of pulling usable data off a squirming 4½-year-old, to why the best AI interpretation Jay has ever seen still only earns a C-minus — this one is about what separates real EEG from "We Map Your Crap." Plus a bonus segment with Joshua Moore on QEEG phenotypes.

durée : 00:58:50 - par : Nathalie Piolé - La playlist jazz de Nathalie Piolé. - équipe : Emmanuelle Lacaze, Fabien Fleurat, Emmanuel Benito Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

Central sleep apnea is a complex and often underrecognized sleep-related breathing disorder that differs from obstructive sleep apnea by involving reduced respiratory drive rather than upper airway obstruction. In this episode, Dr. Ran Liu reviews the underlying mechanisms of central sleep apnea, including the role of ventilatory control instability, discusses its association with neurologic conditions such as stroke, multiple sclerosis, ALS, and myasthenic disorders, and highlights key considerations for diagnosis and management. Learn how emerging technologies, personalized treatment strategies, and advances in sleep medicine are improving outcomes for patients with this heterogeneous group of disorders. In this episode, Teshamae Monteith, MD, FAAN, speaks with Ran R. Liu, MD, FRCPC, MSc, author of the article "Central Sleep Apnea" in the Continuum® August 2026 Sleep Neurology issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Liu is an Adjunct Clinical Assistant Professor at McMaster University in Hamilton, Canada, and an Adjunct Lecturer at the University of Toronto in Toronto, Canada. Additional Resources Read the article: Central Sleep Apnea Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Guest: @SleepyNeuroDoc  Full episode transcript available here Dr Monteith: You may be familiar with obstructive sleep apnea, but central sleep apnea is often less understood and frequently underdiagnosed. In this podcast, we break down the key clinical pearls to sharpen your diagnostic reasoning, discuss why central sleep apnea matters, and to explore some of the fascinating advances transforming the field. Dr Jones: This is Dr. Lyell Jones, editor-in-chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Monteith: This is Dr. Teshamae Monteith. Today, I'm interviewing Dr. Richard Liu about his article on central sleep apnea. This article appears in the August 2026 Continuum issue on Neurology of Sleep. Welcome to our podcast. How are you?  Dr Liu: Good. Thank you, Dr. Monteith, for having me today.  Dr Monteith: Please introduce yourself to our audience.  Dr Liu: Hello, everybody. My name is Richard Liu. I am a sleep neurologist. I am working out of Toronto at both Sunnybrook Health Science Center and MedSleep. I did my residency at Queen's for neurology and my sleep medicine fellowship at Harvard University.  Dr Monteith: Great. And what got you interested in sleep?  Dr Liu: Thank you very much for asking. For me, sleep medicine is a field where essentially everything is connected. Certainly, impaired sleep can affect many other conditions, including many neurological conditions. And even within sleep medicine, when somebody has a sleep disorder, often the entire system is connected. So as an example, if you have insomnia and fragmented sleep and periodic limb movements of sleep, certainly these conditions can impact sleep apnea. And certainly, for today's topic of central sleep apnea, this is an extremely complicated disorder where it's a very in-depth integration between neurological and respiratory physiology, among other systems as well.  Dr Monteith: So, I guess you're kind of like the cornerstone, sleep being the cornerstone of neurology. Everyone has to sleep. That's for sure. Great. So why don't we talk about what central sleep apnea is, and how prevalent is it as a collective group of disorders compared to obstructive sleep apnea?  Dr Liu: So, one way to think about central sleep apnea is that this is a heterogeneous group of etiology. But the primary concept here for central sleep apnea is that there's a reduction in respiratory drive. This is in contrast to obstructive sleep apnea, where essentially this is some form of airway obstruction in the presence of relatively intact respiratory drive. And of course, there's mixed apneas where they may contain features of both. But of course, now we know that even obstructive sleep apnea, there's a certain degree of drive dependence somewhat blurring these distinctions. The overall prevalence of central sleep apnea is about five to ten percent of all patients with sleep- disorder breathing. And certainly, it could be higher in some neurological conditions, such as things like stroke, multiple sclerosis, and multisystem atrophy.  Dr Monteith: Great. So certainly, it's out there. Why don't you tell us about the objectives of your article?  Dr Liu: Absolutely. Thank you for asking. I think the main objective of this article is really to highlight that central sleep apnea is a complex syndrome resulting from a large group of heterogeneous etiologies. And of course, again, it could be associated with many neurological conditions. And really here, I want to highlight advancements, both medicine and technology, on both the side of diagnosis of central sleep apnea, as well as the multimodal targeted treatment.  Dr Monteith: And what do you want our listeners to take away from this talk and certainly your article? What are the key essential points?  Dr Liu: Thank you very much for asking. I think that one way of looking at central sleep apnea to etiologically divide this into both hypocapnic and hypercapnic central sleep apnea. And of course, loop gain being a major driver for a hypocapnic central sleep apnea, and that one can actually think about hypocapnic central sleep apnea beyond a phenotypic spectrum with obstructive sleep apnea, with many patients having overlapping features of both obstruction and central component. On the other hand, hypercapnic central sleep apnea, often also known as hyperventilation syndrome, can span etiology from chemoreflex dysfunction to a broad range of neuroanatomical localization, such as central nervous system, peripheral nervous system, neuromuscular junction, and muscle disorders.  Dr Monteith: And what are some of the symptoms of central sleep apnea? Do any of them differ from obstructive sleep apnea?  Dr Liu: Thank you for asking, that's an excellent question. So certainly, central sleep apnea symptoms can overlap with obstructive sleep apnea symptoms. And of course, given the large range of underlying etiology, often the CSA symptoms depend on the underlying etiology. There may be less snoring compared to obstructive sleep apnea patients, especially the hypocapnic CSA patients. Of course, these patients, like OSA, may have frequent awakenings, gasping and choking their sleep, and nocturia, and so on.These patients may have daytime sleepiness, insomnia-like symptoms, or they could be asymptomatic. Interestingly, the hypocarbnic central sleep apnea patients, they're a bit more prone to have the insomnia-like symptoms, whereas the hypercarbnic central sleep apnea patients, they tend to have a bit more of the daytime sleepiness and morning headaches.  Dr Monteith: You spoke about some of the neurological disorders that might be associated with central sleep apnea, like stroke and multiple sclerosis. What about some of the more traditional risk factors associated with obstructive sleep apnea or conditions associated with it, like obesity and hypertension? Or does that just mix the picture?  Dr Liu: There is many overlap between risk factors between obstructive sleep apnea and central sleep apnea, and certainly one of the things that I highlight in this article is really that often it's not just black and white, that this could be a spectrum with overlapping disease between both conditions. So certainly, in our neurological world, stroke is the most common thing that may be associated with central sleep apnea. But overall, cardiovascular issues such as heart failure, atrial fibrillation, these things can also be associated with central sleep apnea. And again, from the neurological perspective, if we were to divide from hypocarbnic versus hypercarbnic central sleep apnea, by thinking about the hypercarbic central sleep apnea, again, this is where we're thinking about hypoventilation syndromes. You know, anything that can cause neuromuscular weakness, this is something that we should have a high alarm for, that potentially there may be a hypoventilation component. So, things like any myasthenic syndromes and ALS.  Dr Monteith: Great. Why don't we also talk about the classification? When was the last time central sleep apnea's classification was updated, and what should we know about the classification?  Dr Liu: The most recent classification for central sleep apnea is written in the International Classification of Sleep Disorders, third edition. In this edition, it's classified with six central sleep apnea syndromes. So, these are the CSA with Cheyne-Stoke breathing, CSA due to high altitude periodic breathing, primary CSA, CSA due to medication or substance, CSA due to medical disorder without Cheyne-Stoke breathing, and treatment-emergent central sleep apnea. These classifications more so describe the circumstance of when CSA occurs. A more etiological classification that we can consider would be classifying them by the underlying pathophysiology, which is dividing this from hypercarbnic central sleep apnea versus a hypocarbnic central sleep apnea. Certainly, both set of classification are discussed in this article.  Dr Monteith: Yeah. You discussed at length, the major physiological factors that our audience is just going to have to read. I don't want them to hear this too much while they're driving or on the treadmill, cause its super high level. But why don't we just start with some very basic factors that we need to know about this circuitry?  Dr Liu: Perhaps I can start with this concept of loop gain, which is the most important concept under hypocarbnic central sleep apnea. For any one of my colleagues who's listening to this, they're probably laughing right now cause they think that loop gain is my favorite word. So, loop gain is an engineering term referring to the sensitivity of a feedback loop. So, in the context of sleep medicine, this is an overly sensitive respiratory control to carbon dioxide and oxygen fluctuation. There are three components. The main one is controller gain. This is a chemosensitivity predominant to CO2. The second is plant gain, which is the lung's effectiveness for carbon dioxide excretion. And the last is what's called the mixing gain. This is circuitry delay from the time the signal travels from the pulmonary artery to the peripheral and central chemoreceptors. So conceptually, one may think, let's say something decreases your ventilation, so for example, apnea or hypopnea. With this, as you can imagine, when you stop breathing, your CO2 builds up, and this builds up according to the curve of the plant gain. And of course, this build of CO2 signal takes time to go from your lung to your chemoreceptor. That's your mixing gain. And of course, here it meets the overly sensitive chemoreceptors. This is your controller gain. As a result, this results in amplification of your ventilation to the initial respiratory disturbance. So, you have a overshoot of ventilation. All of a sudden, you're blowing out too much carbon dioxide, then you become hypocarbnic. At one point, if you blow out way too much carbon dioxide, your CO2 goes below what's called a PCO2 apneic threshold. After this, if your CO2's below, you essentially stop breathing. And of course, after that, you can imagine your CO2s are building up again. So, when this loop goes over and over, you generate what's called a chemoreflex-driven respiratory oscillation, where you create a crescendo, decrescendo-like flow pattern, which is underneath what we see in periodic breathing in central sleep apnea.  Dr Monteith: So, without going into too much detail, what is the key way to target restoration of equilibrium? Are there anatomical targets, physiologic targets that we're trying to manipulate here? Dr Liu: Again, thank you very much for that wonderful question. There's certainly many approaches that we could do to improve the stability of the system. Certainly, there are treatments for ventilation, either CPAP or in the case of hypocarbon central sleep apnea, things like adaptive servo ventilation. There is also medications that we can certainly discuss later that can double down the entire system for loop gain. Positional therapy can help for many of these patients. For the appropriate patient, improving their arousal threshold can actually reduce arousal-induced amplification of loop gain. Many of these patients, again, if appropriate, certainly weight loss may be helpful, and these are among many things that we can potentially do to improve the ventilatory stability of these patients.  Dr Monteith: Okay, great. But let's also talk about the general overall approach to diagnosing, and much of it is by history, as you mentioned. There's also sometimes a need, as you say, to differentiate out how much is obstructive. So, what is the thinking process there when you're approaching a patient?  Dr Liu: So perhaps I can start with in terms of the diagnostic modalities that we could use for this. So, the gold standard for diagnosis of central sleep apnea is still our polysonogram. The home sleep apnea test sometimes may be harder to distinguish between obstructive and central events. In addition, on a PSG, you have EEG. This allows you to assess for sleep quality and arousals, as well as the EMGs, which can help you pick up periodic limb movements of sleep. And of course, all of these things themselves can affect the central sleep apnea and can be a potential treatment factor.  Dr Monteith: Before we get into treatment, can you just give us, like, the top five or six drugs or drug classes we need to look for so that, you know, we can discontinue or try something else for our patients that might be complicating their presentation?  Dr Liu: Certainly medications, in some cases, can help central sleep apnea, but other cases can certainly be a precipitant of central sleep apnea. So, one thing to consider would be opioid medication. They can certainly cause very complicated central sleep apnea, something called ataxic breathing, where you have irregularity to the tidal volume and the rate of breathing. Other medications such as Oxybate, baclofen, valproic acid, gabapentin, all of which can certainly contribute to central sleep apnea. And of course, in the stroke world, something that we should always think about is that Tetagelor can also contribute to central sleep apnea. And outside of this, things like muscle relaxants, anesthetic agents can also be a contributor.  Dr Monteith: Great. Now let's get into some of the treatment.  Dr Liu: I like to divide treatment into targeting a hypercarbnic central sleep apnea and a hypocarbonic central sleep apnea. For hypocarbonic central sleep apnea, the first line is CPAP treatment. But for many patients, CPAP therapy is insufficient. There's also adaptive servo ventilation, which is an advanced device designed for hypocarbonic central sleep apnea. For hypercarbic central sleep apnea, again, first line is CPAP treatment, with more advanced devices being a bilevel therapy as well as volume-assured pressure support ventilation. There are also medications that can reduce loop gain, with the most researched one being acetazolamide. We can also reduce arousal thresholds, which could be appropriate for certain patients. And for certain patients, improving arousal threshold can be helpful as, especially in hypocarbic central sleep apnea, that arousals can amplify loop gain. Weight loss can be helpful for both hyper- and hypocarbonic central sleep apnea, and we have great new medication on the market for this. Other therapy can include supplemental oxygen that can be added to PAP devices, as well as phrenic nerve stimulation, positional therapy, as well as carbon dioxide modulation.  Dr Monteith: Excellent. So, it sounds like there's a lot of opportunity to help patients. Now, what are you most excited about in terms of latest development for detection as well as for intervention?  Dr Liu: Thank you very much. I'm actually excited about many things in sleep medicine. Perhaps the thing that I'm most excited about in detection in sleep medicine would be the wearable technologies. So, these technologies may use photoplethysmography to detect peripheral artertonometry. This is where we're measuring the pulsatile arterial volume signals as a surrogate of cardiac and respiratory function. And when paired, that was often desaturation. With these technologies, we can actually detect the staging, autonomic arousals, and HI. So of course, these technologies do not have flow, and they do not have EEG. But they're very powerful technology that allows us to do multi-night testing from home. And of course, understanding both the potential limitation of these technology in the context of patients can be very useful. In terms of treatment-wise, we're learning so much about the underlying contributing drivers of different forms of central sleep apnea. So again, this is highlighted in my article that many of these patients needs multimodal targeted treatment, both between either a PAP device in addition to other things such as medication, oxygen, positional therapy, and so on.  Dr Monteith: Great. So, I mean, I think there's so much to this field. Your article is very extensive. Thank you very much for writing this. I know it may have taken a bit of time, and I appreciate you being on our podcast.  Dr Liu: Thank you very much.  Dr Monteith: Again today, I've been interviewing Dr. Richard Liu about his article on central sleep apnea. This article appears in the August 2026 Continuum issue on Neurology of Sleep. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio. 

Healthcare doesn't need more AI pilots. It needs AI that can prove its value. Healthcare organizations are moving beyond experimenting with individual AI tools and beginning to think about AI as enterprise infrastructure. But scaling AI across an entire health system requires more than adding algorithms. It requires integrated workflows, secure technology infrastructure, clinical validation, data governance, and measurable financial and clinical impact. In this episode of The Beat's AI at ViVE series, Sandy Vance sits down with Dr. David Stoffel, Chief Business Officer at RapidAI, to discuss how healthcare AI is evolving from point solutions into enterprise platforms. David explains how RapidAI expanded from its roots in stroke care to a broader clinical AI platform, why health systems are looking to consolidate dozens of AI pilots, and what it takes to connect imaging insights to action throughout the patient journey. The conversation also explores clinical AI, healthcare IT infrastructure, interoperability, AI governance, clinical validation, reimbursement, and ROI. David shares why the next phase of healthcare AI will be defined not simply by what an algorithm can do, but by whether it can produce measurable improvements in clinical care and financial performance. In this episode, they talk about: How RapidAI evolved from a stroke detection tool into an enterprise clinical AI platform Why healthcare is shifting from asking "Why AI?" to asking "How?" The three major challenges healthcare organizations are looking to AI to solve Why clinical impact, workforce capacity, and future-proof IT infrastructure all matter The problem with managing dozens or even hundreds of individual AI point solutions Why enterprise AI platforms can help connect workflows across departments What "deep clinical AI" means and how it can support the patient journey beyond initial disease detection How AI can quantify, visualize, localize, and track disease over time Why seamless workflow integration is critical to making AI useful in clinical practice How hybrid on-premises and cloud infrastructure can improve resilience during cybersecurity incidents Why AI governance and performance tracking are essential for turning a tool into an operational solution How RapidAI is incorporating third-party algorithms into its platform Why clinical validation remains central to successful healthcare AI adoption What CIOs should look for when evaluating AI platforms How health systems can evaluate clinical ROI and financial ROI Why reimbursement can help transform AI from a cost center into a potential profit center Why the healthcare AI market may be headed toward consolidation and simplification Why measurable clinical and financial value will ultimately separate successful AI companies from the rest A Little About David: David Stoffel, M.D., has spent more than 20 years developing and commercializing innovative technologies and services in the medical device industry. David has an extensive track record of success in scaling healthcare businesses. Notably, he led marketing and corporate development at Intuitive Surgical, contributing significantly to establishing the da Vinci surgical robotic system as a new surgical standard of care. He also helped launch and lead the Mobile Cardiac Telemetry business at iRhythm Technologies, one of the fastest-growing digital health companies, and was Chief Business Officer at Ceribell, maker of an innovative point-of-care EEG solution. Earlier in his career, David was a partner at a healthcare venture capital firm, where he invested in and helped build early-stage companies. He started his career in investment banking focused on corporate finance.  At RapidAI, David leads a variety of commercial, clinical, and operational teams, including Marketing, Customer Retention and Success, Clinical Affairs, Training & Education, Corporate Development, and Finance.  David has a BA in Economics from Stanford University and received an MD and MBA from the University of Chicago.

V pondelkových letných epizódach Dobrého rána predstavuje Tatiana Čabáková Slovenky a Slovákov, ktorí sa presadili a zanechávajú výraznú stopu v českej spoločnosti. Jej posledným hosťom je neurológ a neurovedec Martin Brunovský. V Národnom ústave duševného zdravia v Klecanoch vedie klinický výskumný program a dlhodobo sa venuje výskumu mozgu a nových možností liečby duševných ochorení. Martin Brunovský patrí ku generácii vedcov, ktorá v Česku nadviazala na výskum psychedelík zo 60. rokov, prerušený po ich celosvetovom zákaze. Po roku 2000 sa táto oblasť začala znovu otvárať vedeckému výskumu a české tímy patrili medzi pracoviská, ktoré skúmali nielen to, čo psychoaktívne látky robia s ľudským mozgom, ale postupne aj ich možné využitie v psychiatrii. Dnes sa venuje najmä možnostiam liečby ľudí s ťažkými formami depresie, pri ktorých bežné antidepresíva nezaberajú. Spolu s ďalšími českými vedcami skúma psychedelické látky aj v prostredí, v ktorom sa používajú tradične – v domorodých komunitách brazílskej Amazónie. V rozhovore sa dozviete: prečo sa výskum psychedelík v Československu na desaťročia prerušil a ako sa k nemu vedci neskôr vrátili, čo zažíval na vlastnej koži, keď sa zapájal do experimentov s psychedelikami, v čom je ketamín zaujímavý pre psychiatriu, čo ešte chýba k tomu, aby sa psilocybín mohol v Česku používať pri liečbe pacientov aj mimo klinických štúdií, prečo sa českí vedci s EEG prístrojmi vybrali za domorodými komunitami do brazílskej Amazónie a čo tam skúmali počas ayahuascových ceremónií. – Všetky podcasty denníka SME nájdete na⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ sme.sk/podcasty⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ – Odoberajte aj audio verziu denného newslettra⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ SME.sk⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ s najdôležitejšími správami na⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ sme.sk/brifingSee omnystudio.com/listener for privacy information.

In this episode of BioTalk with Rich Bendis, Matt Adams, Chief Executive Officer of BrainScope, joins the conversation to discuss how the Rockville-based company is working to bring objective brain function measurement into real-world clinical care.   Matt shares how BrainScope is using EEG-based technology and artificial intelligence to help decode brain electrical activity and provide clinicians, patients, and care teams with simple, actionable information. He explains why objective data is especially important in brain health, where many assessments can still be subjective, difficult to scale, or dependent on more expensive infrastructure.   The conversation also looks at BrainScope's evolution since winning the BioHealth Capital Region Crab Trap Competition in 2020. Matt discusses how the company has moved from a point-of-care EEG technology focused on traumatic brain injury into a broader AI-enabled brain health platform with potential applications across concussion, brain bleeds, dementia, Alzheimer's disease, and other neurological conditions.   Rich and Matt also discuss BrainScope's FDA-cleared technology, its growing clinical and regulatory foundation, and how the company is using machine learning, deep learning, and a large EEG database to expand what can be measured in brain health. Matt highlights the company's work in Alzheimer's prediction, including data suggesting the potential to identify risk years before typical clinical diagnosis, as well as the opportunity to support longitudinal monitoring and improved CNS trial design.   The episode also looks ahead to BrainScope's next phase, including expanded disease applications, partnerships with clinicians and sports medicine organizations, potential use in clinical trials, global market opportunities, and the company's continued growth in the BioHealth Capital Region.   Editing and post-production work for this episode was provided by The Podcast Consultant.   Matt Adams brings more than 25 years of global healthcare leadership experience developing, commercializing, and scaling medical device, biotechnology, diagnostic product, and service businesses. He currently serves as Chief Executive Officer of BrainScope, a tech-enabled AI software platform focused on brain health. Before joining BrainScope, Matt was President of Invio Automation, a global life science-focused process automation provider. He previously served as Vice President and General Manager of Cerevention, a neuro startup that developed and commercialized platforms to diagnose and treat hemorrhagic stroke and other diseases of the central nervous system. He has also held executive roles at Rebiotix, Cirle, and American Medical Systems. Matt received his eMBA from the University of Minnesota, a Master of Science in Biomedical Engineering from the University of Minnesota, and a Bachelor of Science in Mechanical Engineering from the University of Alaska.

This week a total stranger handed NeuroNoodle his brain. He pulled his own EEG, stripped out every identifying detail, and asked host Pete Jansons and Jay Gunkelman — the man who's read over half a million brain scans — to "read my brain" live on the show. What follows is a rare, unscripted master class: Jay decoding a real, de-identified brain map in real time, with Dr. Mari Swingle on the clinical side. Along the way: how to catch a brain map that's lying to you (Gauss's Law), why a 50Hz hum means the scan is European, how a sleep spindle and an SMR are the same wave, what very fast "glutamate beta" can suggest about a hyper-excitable cortex — and why Jay says the DSM has "no predictive validity" for choosing treatment. Then the reveal: a sharp, high-IQ 25-year-old who moved back home and burned out — and what Jay and Dr. Mari would do about it. Plus Joshua Moore on QEEG phenotypes and the "85%" finding.

“When will be the end of thus exhausting the earth, and how far will avarice finally penetrate?” the Roman natural historian Pliny the Elder asked in 77 AD. Two thousand years later, the answer seems clear. At least according to the contemporary Scottish natural historian James Crawford. In his new book, The Vanishing Earth, the Edinburgh-based Crawford provides dispatches from what he calls the “frontiers of extraction.” From the Atacama Desert in northern Chile to the melting coastline of Greenland, Crawford describes the apocalyptic consequences of our avarice toward the earth. The ultimate frontier of extraction, Crawford warns, is ourselves. Thus he reports on big tech's designs to harvest our thoughts. Consumer headsets are already reading our brainwaves, Apple holds patents for brain-reading earbuds, and another self-styled “leader in real-world neuroscience” once promised “neuro insights for marketing purposes.” The Vanishing Earth's apocalyptic warnings appear both timeless and immediate. Watching Roman miners destroy Spanish mountains, Pliny the Elder wondered when we would finally exhaust the earth. Today, we can quantify the answer. Sometime around 2020, the weight of everything humanity has built came to exceed the weight of all life on Earth. It was just three percent in 1900. We have extracted more in the past fifty years than in all prior human history combined. We now build a city the size of Paris every five days. The ideology of endless growth is only 300 years old, Crawford warns. Pliny the Elder's earth is history. Crawford confesses that he is a product of extraction himself. On his family's windowsill sits a lemonade bottle of the first North Sea crude, siphoned by his father the day it came ashore. “I am Scottish, after all,” he notes wryly. Will our avarice transform extraction into extinction? Not necessarily, Crawford explains. His last dispatch is from Butte, Montana, and offers a ray of hope. There he finds people trying to repair the seemingly apocalyptic consequences of copper mining on the earth. So apocalypse now doesn't mean apocalypse tomorrow. We still have the power to unvanish the earth, the agency to undo the avarice of our ancestors. Five Takeaways •       Pliny's Two Questions. Watching Roman gold miners collapse entire Spanish mountains — ruina montium, “the fall of mountains” — the great naturalist Pliny the Elder asked, two thousand years ago: “When will be the end of thus exhausting the earth, and how far will avarice finally penetrate?” Those two questions run like an entwined seam through Crawford's book, and he believes we're now getting the answers. The ideology of endless economic growth, he argues, is only about 300 years old — born in Enlightenment Scotland as freedom from famine and the caprices of nature, and entirely sensible at the time. The problem is that the planet has changed and the ideology hasn't. The “vanishing” of the title isn't only resources: it's the sixth extinction, the biodiversity collapse — and, potentially, us.•       A Lemonade Bottle of First Oil. Crawford is a product of extraction, and knows it. His great-grandfather fled Shetland fishing at sixteen, wrote “engineer” on his immigration form, and ended up on Ford's very first assembly line building the Model T. His father apprenticed in a coal mine, worked the Zambian Copperbelt, then spent thirty years in oil — which is why Crawford was born on the Shetland Islands, beside one of the world's largest construction sites. The day the first North Sea oil came ashore, his father — who ran the pipelines and knew where to go — filled a lemonade bottle from an outlet valve; it still sits on the family windowsill. “I am a product of extraction. But then we all are”: microplastics in our bodies, forever chemicals passing from mother to unborn child. As a species, we have merged with what we mine.•       Thought Extraction. The journey's final landscape is the mind. Consumer neurotech — EEG headsets promising calm and focus — is already reading brainwaves, and the direction of travel is unmistakable: Emotiv scrubbed “neuro insights for marketing purposes” from its website between fact-check and publication (Crawford found the old language on the Wayback Machine); Apple holds patents for EEG-reading earbuds, with Meta and Snap filing alongside. Rafael Yuste's Neurorights Foundation surveyed the roughly thirty companies selling neurotech to consumers and found that every one of them claimed unlimited access to customers' brain data — with no legal protection in place. The attention economy harvested our behavior; the next extraction, Crawford warns, is the thought itself.•       Heavier Than Life Itself. The statistics that stopped Crawford in his tracks: around 2020, the weight of everything humans have built — buildings, roads, plastics — came to exceed the weight of the Earth's entire biomass, up from three percent in 1900. We've extracted more in fifty years than in all prior history; we build a Paris every five days; in ten years China poured more cement than America managed in the whole twentieth century. Hence the global sand shortage (desert sand is useless — “like building with marbles”) that sent him to Greenland, where melting glaciers make the coastline grow while the world's shrink. And hence the hard questions about the energy transition: in 2025 humanity burned more wood, more coal, and more oil than ever before — not a transition but an accumulation, exactly as the Jevons paradox predicted when Victorian Britain worried about coal. Efficiency doesn't reduce use; it multiplies it.•       The Forever Repair. The book ends not in despair but in Butte, Montana — once the center of world copper production, its open-cast pit now a lake of sulfuric acid in the heart of the city. After thirty years of argument, a settlement around 2020 gave the city something unprecedented: BP holds a blank check to monitor Butte's soils and water in perpetuity, and the people, rather than abandon their home, stayed to watch over it and tell its story. “It's not you fix and you forget. Everything is a repair.” That, for Crawford, is the ideological shift the whole journey points toward — from extraction to repair. He is hopeful for one precise reason: we got here through a way of seeing the world, and minds can change. In the tradition of Silent Spring — which banned DDT and birthed the EPA — a book can still move the world. “I am Scottish, after all” — but the glass, on inspection, is half full. About the Guest James Crawford is a Scottish writer, broadcaster, and historian based in Edinburgh. The author of Fallen Glory: The Lives and Deaths of History's Greatest Buildings and The Edge of the Plain: How Borders Make and Break Our World, he presents book programmes for the BBC and spent over a decade with Historic Environment Scotland. The Vanishing Earth: Dispatches from the Frontiers of Extraction (Bloomsbury, 2026) is out now in the US, with the UK edition imminent from Scribe. The New York Review of Books places him with Iain Sinclair, Rebecca Solnit, and Robert Macfarlane: “Riveting.” References: •&nb...

Advances in sleep technology are transforming how neurologists identify and manage obstructive sleep apnea, a condition that affects up to 70% of patients with certain neurologic disorders and can negatively impact cognitive and neurologic outcomes if left untreated. In this episode, Dr. Joyce Lee-Iannotti discusses the growing role of wearable and nearable sleep-monitoring devices, when home sleep studies are appropriate, and how emerging technologies are expanding access to diagnosis and treatment. Learn practical strategies for screening patients, interpreting sleep data, and partnering with sleep specialists to improve long-term neurologic health through better sleep. In this episode, Casey S. Albin, MD, FAAN, speaks with Joyce K. Lee-Iannotti, MD, FAAN, FAASM, author of the article "Sleep Diagnostics and Monitoring Technology in Obstructive Sleep Apnea" in the Continuum® August 2026 Sleep Neurology issue. Dr. Albin is a Continuum® Audio interviewer, associate editor of media engagement, and an assistant professor of neurology and neurosurgery at Emory University School of Medicine in Atlanta, Georgia. Dr. Lee-Iannotti is a Professor of Neurology at the Barrow Neurological Institute, University of Arizona College of Medicine, and Creighton School of Medicine in Phoenix, Arizona. Additional Resources Read the article: Sleep Diagnostics and Monitoring Technology in Obstructive Sleep Apnea Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @caseyalbin Guest: @jleeiannotti Full episode transcript available here Dr Albin: Through the neurology of sleep issue, I think we have all been convinced that we all need better sleep, both for ourselves and for our patients. And fortunately, there is an abundance of new technology that can enable us to diagnose sleep problems, and then also make sure that our patients are getting the rest that's going to give them the best chance at a good cognitive recovery, and improve their cognitive function even if they are not currently suffering from a neurologic condition. Today, I am so excited to dive deeper into this topic.  Dr Jones: This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Albin: Hello, this is Dr. Casey Albin. Today I'm interviewing Dr. Joyce Lee-Iannotti about her article on sleep diagnostics and monitoring technology in obstructive sleep apnea. This article appears in the August 2026 Continuum issue on neurology of sleep. Welcome to the podcast, I'd love to just start by having you introduce yourself to our audience.  Dr Lee-Iannotti: Sure. Thank you so much for having me, Dr. Albin. I'm Joyce Lee-Iannotti. I'm a professor of neurology at Barrow Neurological Institute. I am boarded in general neurology, stroke, and sleep, but I spend most of my time in the sleep world, so I jokingly say that I get more sleep doing sleep than I certainly did in stroke.  Dr Albin: Absolutely. I mean, wow, what a fascinating career, and I suspect that we're actually gonna get to some of how all of those pathophysiologies might overlap in the world of sleep. But you had the really exciting task of trying to distill this exciting, rapidly evolving field of sleep diagnostics, and I suspect it's relevant to many of the patients who end up in the neurology clinic, and I suspect that it's actually pretty relevant to many of our listeners who themselves might actually be wearing sleep tracking devices. And all of us probably wonder, well, how can we use that data to improve our own cognitive function and certainly make our patient's life even better? Before we even get into some of the meat and potatoes of this, I thought it would be really helpful for us to define some terms that come up in your article, one of which is wearables. We might figure that out, but the other is nearable. Walk us through what's a wearable, what's a nearable, how are they different?  Dr Lee-Iannotti: I'm happy to do that. First of all, the article is entitled Sleep Diagnostics and Monitoring Technology, and this was a super fun article for me to write because it's very practical, and it's generalizable to everybody. So, I'm going to start with a wearable, and a wearable is really a device that is simply worn on the body. And we're all familiar with wearables like smart watches, they're rings, they're patches, they're headbands, and the most validated form of a wearable that you've probably heard about is actigraphy, which we use in the sleep clinic.  Dr Albin: Tell us a little bit more. So, what is actigraphy? I've heard the word before, but don't actually know what it means.  Dr Lee-Iannotti: Actigraphy has been a tool that we've used in the sleep clinic for a really long time. Traditionally, we used it to monitor circadian rhythm patterns in people who are night owls or morning larks. And then more currently, we actually use it to track sleep patterns in people with suspected narcolepsy. So, before they come in for a sleep study, we actually have them wear an actigraphy for about a week just to get a sense of their sleep duration and their circadian pattern.  Dr Albin: Got it. And what is it monitoring? Our movement or the patterns that we may or may not make?  Dr Lee-Iannotti: It's really based on movement. You're exactly right.  Dr Albin: Cool. Okay, so most of this is based on gold standard monitoring with actigraphy. What other things can be incorporated into these wearable devices?  Dr Lee-Iannotti: Yeah, the technology is really advanced, and every day it changes, which is super exciting. So, on top of movement, these wearables can look at temperature. They can look at even EEG, like limited EEG, heart rate variability, and a really big word that we like to use in sleep technology, which is PPG, or photoplethysmography data, and that's really looking at heart rate variability and oxygenation, saturations, and following those levels as well.  Dr Albin: Wow, so you basically can get most of the data that you might have historically needed to go to a sleep lab to get.  Dr Lee-Iannotti: Most of them. They're still a surrogate. You'll hear me emphasize in the article as well that the gold standard remains the in-lab polysomnogram, but these are good surrogate markers that patients can wear long term to look at trends and patterns.  Dr Albin: Absolutely. And we're gonna unpack a little bit about who specifically those are best for and, really what it gives you in the clinic. But before we jump into that, what's a nearable, and how is that different?  Dr Lee-Iannotti: Yeah. Nearables are really exciting too. So, these are devices that monitor sleep but don't require direct contact on the body. So, these are devices that our patients will use, but it'll be at the bedside table. They're devices that actually go underneath the mattress, or they can be in, like, the ambient environment to detect sleep patterns.  Dr Albin: Oh my gosh. How is it doing that if it's not actually something you're wearing? Dr Lee-Iannotti: I know. It seems a little Big Brother-ish, doesn't it?  Dr Albin: Yes.  Dr Lee-Iannotti: So, they use a technology called radio frequency signals, sometimes radar, sometimes sonar, pressure sensors, even microphones, and they're picking up things like respiration, movement, snoring, and that's how they can decipher sleep patterns.  Dr Albin: Crazy. I mean, I guess the benefit of that is that it's less disruptive to the user 'cause it's not actually on them and having contact with them, and I suspect there's probably some downsides in terms of just it's a more limited data set you're getting.  Dr Lee-Iannotti: Absolutely. Yeah, you're exactly right. It's more convenient because it's not touching them, so, in theory, they're gonna sleep more comfortably. But I would like to think that the most validated forms of devices that we use to track sleep have to have some form of contact with the body, and this technology is new and probably needs a few layers of more sophistication to be as accurate as the wearables.  Dr Albin: Absolutely. I feel like we're going to have this conversation in five, maybe even less than that, years, and this data will have become like, oh, we all have something in our room that's monitoring everything. The world is crazy. All right. One of the places where your article really stood out to me is that sleep diagnostics have really taken off, particularly when we're thinking about obstructive sleep apnea. And I think we all might sort of scratch our heads and be like, "This is a neurology podcast. Why should I, as a neurologist, care about obstructive sleep apnea?" But I think you laid out a very convincing argument in the article. Walk us through why we should care about this.  Dr Lee-Iannotti: Absolutely. So, for neurologists, sleep matters, and I hope that my article translates that. Obstructive sleep apnea, which I'm gonna call OSA, is incredibly common in all of our neurologic patients, whether you see epilepsy, Parkinson's, stroke, Alzheimer's, neuromuscular, or even chronic headache patients. The prevalence of sleep apnea is as high as 70% in these patients.  Dr Albin: Wow. That's incredible. That is an incredibly high number.  Dr Lee-Iannotti: And if I can add, Dr. Albin, there's growing literature in multiple studies across the literature that show that untreated sleep apnea negatively impacts neurologic outcomes in our patients. So, it is really important to ask the question about sleep, and if the red flags pop up, to then screen for sleep apnea in particular.  Dr Albin: I think that that's a great point for us to drill down on, and obviously you're a sleep neurologist. You're very used to screening people in the clinic. But say someone comes in, and I'm gonna have you put your former stroke hat on, and say someone comes into the stroke clinic, and you're just making sure that they're optimized on their aspirin or dual antiplatelet therapy, and you're doing secondary risk modification. How would screening for OSA fit into that?  Dr Lee-Iannotti: It would be a part of that screening process to look at preventative ways to prevent strokes, whether it be primary or secondary prevention. So, we did a survey a while back, and it actually showed that 17% of stroke neurologists are screening for sleep apnea. It has quadrupled, fortunately, in the last few years due to public awareness and a lot of education that the AAN has done, in fact. So, at this point, I would say not asking about sleep apnea to a stroke patient is similar to not asking about diabetes.  Dr Albin: So, we really have to be cognizant and conscious about saying, you know, "Do you snore at night? Do you have episodes of apnea, or does someone witness you stop?" Are there things that you ask that maybe I wouldn't be aware and thinking of?  Dr Lee-Iannotti: Those are the right questions, and then very practically, very easy questionnaires to implement that literally take a minute that your nurses or medical assistants can administer to the patient, and the most commonly one that is used in stroke patients is called the STOP BANG, S-T-O-P B-A-N-G, which is a validated questionnaire to screen for symptoms.  Dr Albin: Absolutely. So okay, so this is easy to do. We should all be doing this. If you're not, now's the time. And I suspect if they screen positive, next steps, it can be hard to get into a sleep lab, and we're gonna talk about some workarounds, but I think some of our listeners may never have spent time in the actual sleep lab. So, let's say you refer a patient and you actually can get them in for a gold standard in-lab sleep study. What's gonna happen in that sleep study?  Dr Lee-Iannotti: Yeah. And I just want to preface this by saying that my article hopefully highlights that we've come a long way where we understand that there are many neurologic populations then that can undergo home ambulatory sleep studies with just as much accuracy as an in-lab polysomnogram. But with that, I wanna say an in-lab polysomnogram is actually a highly sophisticated physiologic recording overnight, typically, unless somebody is a day sleeper. So, if I could take a minute to kinda describe the data that we're monitoring throughout the night. There is a limited EEG. We concentrate on frontal, central, occipital leads to look at sleep staging. We have eye leads. We have EMG leads on the chin and the leg. We look at EKG, flow monitors, belt, and then we also do pulse oximetry, snoring mics, and even body position sensors. So, a lot is going on.  Dr Albin: This is incredible. Yeah, it truly is. I mean, this is like... I'm a neurointensivist, and so I think that you have just really outdone what I consider multimodal monitoring in your sleep study patients. I'm not even sure our neuro ICU patients accumulate that much data. All right, so tell me, they go through, and they can get this. But like you said, there's actually a lot of data that you've presented that, you know, not everyone needs to go to the in-lab sleep study. So how do you decide who actually needs to be in a sleep lab versus who can do this at home? And then how do you set them up with getting this done at home?  Dr Lee-Iannotti: Yeah. The home sleep studies are really more accessible ways for us to assess for sleep apnea in our neurologic patients, especially patients who live in very rural areas and don't have access or have very long wait times for an in-lab polysomnogram. With that being said, though, Dr. Albin, I will say that there are a subset of patients who have to go into the lab, and those are patients where you suspect a sleep disorder other than obstructive sleep apnea, so like parasomnias or central sleep apnea, patients with severe cognitive or physical debilitation, like our stroke patients who are hemiplegic and won't be able to apply the home sleep study. But for the most part, I do feel like a home sleep study is a good beginner study to screen the patient. And if there are red flags, then you can always get the in-lab afterwards.  Dr Albin: That's super helpful. And just from a pragmatic standpoint, will insurance cover the home sleep study?  Dr Lee-Iannotti: They will, yes, and it's all about documenting. So, if I could get really practical, for neurologists, it really just requires documenting snoring, for one, whether it's noted by the patient or by their bed partner, and then any form of hypersomnia, which is daytime sleepiness or even a sense of fatigue, having low energy or napping during the day.  Dr Albin: I suspect so many of our patients meet those criterias. That seems, like, wildly simple to do.  Dr Lee-Iannotti: Yes. And if you wanna be the favorite referral person to your sleep neurologist or your sleep specialist, then take another step and do that STOP-Bang. And if you record a score greater than three, that automatically gets them at least a home sleep study.  Dr Albin: It's amazing. And then when you get this data, again, this is really practical, pragmatic stuff, how do you get the report? Does it integrate in your electronic medical record? Does the patient bring it in? How do you get that data back?  Dr Lee-Iannotti: Yeah, so this is where technology is amazing, Dr. Albin. Now we have disposable devices. Sometimes they sync to the WatchPat, or the greater Wi-Fi. So we can get them all through password-protected internet forums that transmits the data, so sometimes the patients don't even have to come back to give us the data. And then we have different forms where we can actually relay the results as well, either through the electronic medical record or through systems themselves to relay those results directly to the patient.  Dr Albin: Yeah, and your article really laid out in beautiful tables, like, all the different devices that are available to patients, and it's honestly mind-blowing how many of these companies and devices exist. So, seems like the world is your oyster in terms of picking from them.  Dr Lee-Iannotti: Absolutely. I think there's... The last time I counted, there was over 20 different home sleep study devices for obstructive sleep apnea. And it's a great thing to have, but sometimes too many choices can be a little bit confusing. So that's where I do say partner with your sleep specialist close by, and they will find the right type of home sleep study device for your particular patient.  Dr Albin: Drilling down a little further, let's say your patient does get diagnosed with OSA. One of the things that really stuck out to me is that there's a whole range of now devices that are new that make this treatment easy so that we can actually prevent and treat neurological conditions by just improving patient sleep. So, walk us through a little bit about how that landscape has changed.  Dr Lee-Iannotti: Sure. And I'll start with the gold standard of treatment, which is still CPAP, which is continuous positive airway pressure. Not only can we monitor the pressure, look at adherence, change the humidification for the patient all remotely through, again, password-protected internet forums, but we can even change the pressure with patients 300-plus miles away.  Dr Albin: Wow.  Dr Lee-Iannotti: It's really cool, right? It prevents patients, especially with significant neurologic debilitation, from having to come into the office for adjustments. The other thing I wanted to mention, Dr. Albin, is for patients, a lot of patients like positive feedback on a daily basis. And a lot of these companies, if you are on CPAP, have come up with a smartphone app that you can look at how many hours you used your CPAP device. They give you a score, and they even tell you how many times you had stoppage of breathing that night.  Dr Albin: I think that this is what's really exciting about where we are in neurology and, like, neurologic care, is we have gotten so much better at getting patients their own data and allowing people to really see that data, integrate lifestyle changes, and see how it impacts them. And that positive feedback loop, I think, is a really powerful tool for our patients to say, "Look, this makes me better," or, "Oh, this makes me worse." I'm just really excited by how much data we can give directly to our patients.  Dr Lee-Iannotti: I agree. It's so empowering. You know, as a CPAP user myself, you want that positive affirmation that all of your efforts at night and cleaning your mask and your machine paid off, and everybody likes to see an A+ on their report card.  Dr Albin: I love that. Now I'm going to ask you on the flip side, I imagine, and I myself am a sleep tracker, like I have my little device and I look at, you know, the score in the morning and I kind of perseverate on like what makes it better, what makes it worse, and I can imagine that sometimes in sleep clinic, people are coming in to you and they have just pages and pages and, you know, they're flipping through all their data from the last year. And I imagine that's pretty overwhelming when you have just the insane amount of data that these devices can generate. So, from another pragmatic, practical standpoint, how are you integrating all that data when someone comes in for a sleep visit?  Dr Lee-Iannotti: I love that question. So first of all, I will say myself, and I think a lot of my sleep colleagues, we love objective data, right? Because it's something that we can see. We can see whether it matches their subject's symptoms. Sometimes it can be a lot of reassurance that, "Look, you actually got more sleep than you thought you did." But sometimes patients will bring in like a month's worth, and that's really hard to analyze, you know, in a 30 or 60-minute visit. So oftentimes what I do is I look at like the last week or last two weeks, and I look at trends. And I think a lot of the apps for whatever device you decide to use have done a really good job in terms of visual graphics to show how much sleep on average you're getting, how much deep sleep or REM sleep or wake-up times that you have. So, I, again, I feel like the technology has really helped us consolidate a lot of data, but also be efficient with the messaging that we relay to our patients.  Dr Albin: Absolutely. And I know personally, at least for the sleep tracker I wear, it also allows you to diary. So, you can say like, "Oh, last night I had a glass of wine," or, "Yesterday I had a really hard workout," or, "I stayed out late with friends," or, "I was on call." Turns out call is really, really bad for my sleep. But it does allow you to sort of track what behaviors, and I wonder how much of that informs what you're counseling patients to do in terms of trying to notice the things that either improve their sleep performance or their subjective feeling of restlessness or restfulness, and how all of that plays into what you're doing in the clinic.  Dr Lee-Iannotti: I love all of those comments. It is validation for the patient. Again, it's empowering for them to look at, what did I do last night to get more REM sleep than the night prior? I want to mention that the best people who do this so well are professional athletes, and they look at, how am I going to cater my day to make sure that I'm sleeping well, that I reduce my risk of injury and concussion and increase my reaction time? And I feel like all of us should do that. That's such a great philosophy, to analyze how we can do things better.  Dr Albin: I love that. This whole issue, but this article in particular, really emphasized to me that sleep, again, it's not a passive time that we're taking a nap. It's a really active form of sort of neurologic healing. There's important removal of toxins through the lymphatics. And like there's a lot happening in sleep, and there are so many more tools that allow us to unpack that sort of peak performance of sleep, which again, sort of is that athletic mentality of like, how can I make this better? Not just to treat a neurologic condition, but also really importantly, to prevent one.  Dr Lee-Iannotti: I often refer to sleep as icing on the cake. With our patients, when you're doing everything right, for example, a multiple sclerosis patient, they're on the right medications, they are exercising, they're participating in rehab, their mood is good, but they're just not getting to the quality-of-life metric that they want to be, it usually is sleep. And if you can add that as a neurologist to your piece of the algorithm to help your patient, it really does improve their quality of life and ultimately their neurologic outcome. I'm a true believer of that.  Dr Albin: I was a true believer. I've been made even more of a true believer through your article and getting to talk to you. I always like to close by asking the person I'm interviewing, what's one really exciting thing in this field? What are you kind of most looking forward to as you think about sleep medicine and its impact in neurology in the next five or 10 years?  Dr Lee-Iannotti: Oh, I love that question, too. So, the thing I'm most excited about in the field of sleep, and specifically sleep neurology, is the power of preventative care. When I did a lot of stroke, I would see young people, older people, healthy people, people with a lot of genetic risk factors come in, and one minute they were totally normal. The second minute, they're paralyzed and can't speak. And for a lot of these patients, I would ask, "Why am I seeing you now? Why couldn't I have seen you 10 years earlier, worked on risk factors, and prevented this outcome?" And I truly believe that is exactly where sleep lies. If you work on sleep, whether you're an adolescent, 20 year old, 30, et cetera, you are ultimately going to prevent horrible cardiovascular, cerebrovascular, neurologic diseases in the long run.  Dr Albin: So important. I really want to direct our listeners back to your article because all of the articles are really practical, but this one in particular looks at how do you do this? What are your options? How do you get this to patients? It really is sort of a step-by-step guidebook on like, A, why this is important, how you should screen, what you should do if someone screens positive for needing to have a sleep study.There's so much more technology that allows really anyone anywhere to have access to the testing that they need to get the right diagnosis, to improve their sleep, to improve their cognitive outcomes, to improve their neurologic health. It's pretty amazing.  Dr Lee-Iannotti: It is amazing. And in the article, I do allude to certain devices and then websites that are very helpful. If I can announce, Dr. Albin, I'm super excited about this. Through work with the American Academy of Sleep Medicine, endorsement with the AAN, we are coming out with a new clinical guideline specifically on home sleep study devices and looking at the validation studies. So, I think that's going to be very helpful. But I hope that everybody after listening to this picks up the phone, call your friendly sleep specialist, and align with them and partner with them. And this will ultimately help your patients, I guarantee it.  Dr Albin: Again, today I've been interviewing Dr. Joyce Lee-Iannotti about her article on sleep diagnostics and monitoring technology in obstructive sleep apnea. This article appears in the August 2026 Continuum issue on Neurology of Sleep. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners, and thank you, Dr. Lee-Iannotti, for joining us today. Dr Lee-Iannotti: Thank you.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audiocme. Thank you for listening to Continuum Audio. 

How Neera's Vibroacoustic Bed Helps You Fall Asleep Faster"If you sleep this way, you wouldn't want to sleep another way.”When Igor said this, I had to go and try out the Neera bed myself, and afterward I interviewed Igor about the innovative science and technology behind Neera. It is a device designed to improve sleep through vibrational frequencies and personalized algorithms. In our conversation we explore how this technology can transform sleep quality and overall well-being.Topics:* Science of vibrational frequencies and sleep* Personalized algorithms for sleep optimization* Acoustic and mechanical engineering in sleep devices* The role of frequencies in regulating nervous system and chakras* User experience and self-reporting in sleep tech* Future developments in vibrational sleep technologyTimestamps:* 0:33 Who Igor is and what Neera does* 1:19 Why he built it: devices measure, apparatuses act* 2:57 Why sleep is the highest-leverage longevity target* 4:05 “See how it feels” and the phrase that sold it* 5:30 Where standard sleep advice runs out* 6:32 The mechanism: frequencies through touch, not ears* 9:48 Do solfeggio frequencies and brainwaves connect?* 11:24 Making 2 Hz on a mattress without a giant speaker* 12:38 Composing a state, and AI programs on request* 15:02 Personalization: wearables, self-reporting, onboard sensors* 17:23 Nina's session, and the cat purr program* 20:12 Chakra frequencies and the 96% blind test* 21:54 Inside the mattress: actuators and waveguides* 24:57 Validating with EEG and the cost of clean sleep research* 27:05 Day programs vs night programs* 28:43 Who it works best for: athletes, NSDR, day reboots* 29:58 Sleep inertia and the 3am wake-up* 32:53 Catching micro-wakeups and returning you to sleep* 35:06 The first week, and napping vs the 20-minute program* 39:12 Hardest part: hardware or software?* 41:15 The one non-responder* 42:09 Launch & Founders ClubABOUT IGOR:Igor is the co-founder of Neera. They are building nervous system regulation hardware for high performers. Over 15+ years in deep tech, he was design director on YotaPhone, the first dual-screen smartphone, and co-founded Gero (disease prediction from wearable movement data) and Atmotube (air quality sensing, 70,000+ units shipped, used in research at Stanford and Harvard).CONNECT WITH NEERA:* Website: https://neeralab.com/* Neera LinkedIn: https://www.linkedin.com/company/neerasleep/* Igor's LinkedIn: https://www.linkedin.com/in/igorme/ABOUT NINA'S NOTES: Nina's Notes explores the intersection of longevity science, neuroscience, and human optimization. Hosted by Nina Patrick, PhD in pharmaceutical sciences and longevity researcher, each episode translates cutting-edge research into actionable insights for living longer, better.CONNECT WITH NINA'S NOTES* Newsletter:https://www.ninasnotes.xyz* LinkedIn:https://www.linkedin.com/in/ninapatrick/* Website:https://www.ninapatrick.xyz Get full access to Nina's Notes at www.ninasnotes.xyz/subscribe

Jay Gunkelman has read more than half a million brain scans — and this week he and host Pete Jansons open the Brain Bar with a claim that sounds impossible: your brain is lying to you about time itself. In the experiments Jay walks through, a person's body reacts emotionally to an image seconds BEFORE a random generator has even chosen which image they'll see. From there the panel takes your live questions across the map: the anxiety medications that quietly dig a two-year hole, kids told to remove part of their brain for epilepsy who turned it around another way, what autism, ADHD and addiction secretly share on an EEG, and how your alpha rhythm changes across your whole life. Plus Joshua Moore's intro to QEEG phenotypes — and Josh's own story of beating "incurable" torticollis after Walter Reed told him he'd end up in a wheelchair.

Have you ever wondered when exactly you should be getting an EEG to capture an unusual baby movement? Featuring pediatric epileptologist Dr. Eva Catennacio of the Children's Hospital of Philadelphia, this episode focuses on the intricacies of an infantile spasms syndrome diagnosis. Tune in to learn when to order an EEG, how to diagnose infantile spasms, and the benefits of early effective treatment. 

Obstructive sleep apnea affects approximately one in four adults and is especially common among patients with neurologic disorders, including stroke, Parkinson disease, dementia, epilepsy, and neuromuscular conditions. In this episode, Dr. Stephanie Stahl discusses why neurologists should routinely screen for OSA, highlights key symptoms and risk factors, reviews important considerations when interpreting sleep studies, and outlines current treatment options beyond CPAP. Learn how recognizing and treating sleep apnea can improve quality of life, optimize management of neurologic disease, and reduce long-term health risks. In this episode, Aaron L. Berkowitz, MD, PhD, FAAN, speaks with Stephanie M. Stahl, MD, FAASM, author of the article "Obstructive Sleep Apnea" in the Continuum® August 2026 Sleep Neurology issue. Dr. Berkowitz is a Continuum® Audio interviewer and a professor of neurology in the Department of Neurology at the University of California, San Francisco, in San Francisco, California. Dr. Stahl is an Associate Professor of Clinical Medicine and Sleep Medicine Fellowship Program Director at Indiana University School of Medicine in Indianapolis, Indiana, where she also serves as Sleep Laboratory Medical Director in the Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine. Additional Resources Read the article: Obstructive Sleep Apnea Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @AaronLBerkowitz  Full episode transcript available here Dr Berkowitz: Obstructive sleep apnea is very common. It can cause or contribute to common neurologic symptoms, such as headache and impaired cognition, and it's a risk factor for stroke. And yet, if you're like me, you may not know too much more about sleep apnea than that. Today, I have the pleasure of talking to sleep expert Dr. Stephanie Stahl to learn what every neurologist should know about OSA.  Dr Jones:  This is Dr. Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast.  Dr Berkowitz: This is Dr. Aaron Berkowitz. Today I'm interviewing Dr. Stephanie Stahl about her article on obstructive sleep apnea. This article appears in the 2026 Continuum issue on Neurology of Sleep. Welcome to the podcast, Dr. Stahl, and could you please introduce yourself to our audience?  Dr Stahl: Yeah. Thank you for having me. I'm a sleep medicine physician and neurologist and medical director of the Indianapolis Sleep Lab at Indiana University Health. I serve as the director of the Sleep Medicine Fellowship program. I'm faculty advisor for our very first student interest group in sleep medicine at Indiana University School of Medicine. I'm also actively involved in some national leadership roles, including the incoming chair of the American Academy of Sleep Medicine's Education Committee and co-chair of the Academy's Inter-Scorer Reliability Gold Standard Panel. So, I really appreciate this opportunity. I look forward to our discussion.  Dr Berkowitz: Me too, and we appreciate the opportunity too to get to talk to you. You have so much expertise in this area, and I certainly encourage our listeners to look at your article, which is very comprehensive and up to date, and I learned a ton from it. I didn't get much exposure to sleep neurology as a trainee, and I've always worked in academic centers where we have a sleep group and we can refer patients there. So, I have to admit, sleep may probably be the area of neurology I know the least about, and felt like I was learning something new from pretty much every line of your article, and I know our readers will too. So, your article has a lot of excellent detail for our readers on the diagnosis and treatment of this very common condition. But I'd like to keep our interview relatively high level today and focus on the essentials for the practicing general neurologist. So, to start, can you just give us a sense of what obstructive sleep apnea is, and what every neurologist should know about it?  Dr Stahl: Yeah. So obstructive sleep apnea is characterized by either partial or full obstructions in the upper airway. That may sound pretty simple, but this leads to a whole bunch of issues. It leads to oxygen desaturations, arousals from sleep, leading to sleep fragmentation. This can then lead to sympathetic nervous system activation, cerebral hypoperfusion, leading to a whole bunch of symptoms or neurologic conditions.  Dr Berkowitz: Great. And you mentioned this in your article, but just to emphasize, how common is obstructive sleep apnea in the general population?  Dr Stahl: Yeah. So, about a quarter of the general population have obstructive sleep apnea. Much more common in many neurologic conditions.  Dr Berkowitz: Yeah, so very common disorder. We are seeing patients with it quite frequently, whether that's the reason they are seeing us in neurology or not. And this leads to my next question, which is what neurologic symptoms or presenting concerns of a patient should make us think about OSA and the differential diagnosis, and what factors based on the history or the exam or the context would make you suspicious for OSA as the cause of a neurologic symptom? In other words, the patient's presenting with classic symptoms of OSA, and that's why they're seeing a neurologist or seeing a primary care doctor, but is coming for evaluation of, say, headache or other symptoms. And what symptoms would make you think of wanting to consider OSA, and then what aspects of the history or otherwise would make you want to evaluate the patient for OSA?  Dr Stahl: I think a really important takeaway is for neurologists to know that obstructive sleep apnea is very common in neurologic conditions and has that potential to worsen a lot of these conditions or their associated symptoms. And so, it should be on our radar. There are certainly some basic questions and signs and symptoms that we can ask patients about or, or take a look at on exam. And so particular symptoms include snoring. Anybody that snores loudly or frequently, that's a strong risk factor for obstructive sleep apnea. If someone's seeing them stop breathing in their sleep, if they are waking up a lot throughout the night. There are some other symptoms that we may not necessarily attribute upfront to obstructive sleep apnea, such as nocturia, nocturnal reflux, night sweats. There are some daytime symptoms, of course, too, like unrefreshing sleep, daytime sleepiness, morning headaches, an important one in neurology. And then we take a look at the patient's exam. And so, some things that neurologists might want to be thinking about are people with obesity are certainly at a risk for obstructive sleep apnea. But it's also very important to know that someone does not need to have obesity in order to have obstructive sleep apnea. We look at neck size, other morphologic characteristics, such as how much that we can see in the back of their mouth. Can we see their uvula? Does their tongue size appear large in their mouth? And then some other risk factors too, such as male gender, older age, family history, post-menopausal state in women. All that being said, though, sometimes in neurologic conditions, we don't have all of those symptoms or risk factors to be thinking about. And so, in certain neurologic conditions such as stroke where obstructive sleep apnea is very common and has the potential to increase the risk of another stroke, we may need to be thinking about testing these patients even with minimal symptoms or other risk factors.  Dr Berkowitz: That's very helpful. So, you mentioned their headache might be the presenting symptom, right, to a neurologist, and we should certainly be thinking about obstructive sleep apnea as a potential diagnosis, even the cause of the patient's headache, particularly you said patients with morning headache. I often try to think about in patients presenting with, for memory loss, or other cognitive concerns, and that may be due more to inattention from poor sleep, so asking about sleep and symptoms of sleep apnea in those contexts. Are there any other presenting neurologic symptoms not particularly related to sleep? I'm thinking of headache, memory loss, other symptoms that would make you think, "Oh, I should actually screen this patient for sleep apnea also."  Dr Stahl: Yeah, other symptoms to think about in pediatrics, hyperactivity, people that have impaired vigilance, as you alluded to, that poor attention. Sometimes people get misdiagnosed with ADHD, and it's actually just a manifestation of obstructive sleep apnea.  Dr Berkowitz: You alluded to this, Dr. Stahl, that stroke, for example, patients are at higher risk of developing sleep apnea as a result of stroke, and it's also a risk factor for stroke. What other neurologic conditions, primary neurologic diseases, put patients at a higher risk of OSA? And again, similar to the last question I asked you, what are some clues that we should evaluate for? We might be following a patient for their post-stroke care over time and not necessarily thinking about diagnosing a separate condition in them since we're following them for their stroke or their degenerative disease. What are the conditions that put patients at a higher risk of OSA as a result of the condition, and then when would you think about screening them for it?  Dr Stahl: Some particular neurologic conditions where obstructive sleep apnea are very common, in addition to stroke and, and TIA, include Parkinson disease. It can worsen a lot of the motor, cognitive symptoms, sleep disruption that we can see in Parkinson disease. Very common in all causes of dementia, but in particular Alzheimer disease and Lewy body dementia. Very common in neuromuscular conditions. We should definitely have obstructive sleep apnea and all forms of sleep-disordered breathing high on our radar. In conditions like myotonic dystrophy. Charcot-Marie-Tooth is another one where obstructive sleep apnea is very common. Myasthenia gravis, it can worsen the symptoms of that. In particular, a pearl is if somebody has morning weakness in myasthenia gravis, obstructive sleep apnea should be high on your radar. And also, as you mentioned, any forms of headaches. There are some other things too. If somebody has poor seizure control, especially nocturnal seizures, you might have obstructive sleep apnea on your radar as well.  Dr Berkowitz: So, I think you've covered essentially every category of neurologic disease, right? We have cerebrovascular, movement, neurodegenerative, neuromuscular, epilepsy, all conditions where either the disorder itself, such as stroke or the, correct me if I'm wrong, the neurodegenerative disease puts the patient at risk. Or the patient may be at risk for exacerbations of their disease, as you mentioned in myasthenia. I love that pearl. Not fatiguable at the end of the day, but if the patient with myasthenia is telling you they're feeling weaker at the beginning of the day, then think about obstructive sleep apnea and that obstructive sleep apnea worsening control of epilepsy due to poor sleep. So really a lot of bidirectional interactions with this common condition. Okay, so if we're concerned about obstructive sleep apnea, again, myself, a general neurologist speaking perhaps on behalf of other general neurologists, we see a patient with headache or reporting memory loss that we find to be impaired attention, or we see exacerbation of their underlying primary neurologic disease. As you mentioned, we think, "Oh, I've listened to this podcast. I've read Dr. Stahl's article. I should probably be thinking about OSA in this patient, and I should order a sleep study." Now, I admit when I get the sleep study back, I scroll to the bottom, I see they do have obstructive sleep apnea, I'm going to send them over to a sleep specialist. But for the general neurologist, what are some high-yield pearls and some pitfalls to be aware of when we get sleep studies for obstructive sleep apnea, and we are looking at the results? Dr Stahl: The first thing is to understand that there are two main types of sleep studies: in-lab polysomnography and home sleep apnea test. In-lab studies are typically what we consider the more accurate type of study. Main reason for that is that we have EEG, so we can see if someone is awake versus asleep. Most home sleep apnea tests do not utilize EEG, and so when we're looking at respiratory events, apneas or hypopneas, we're looking at over the total recording time rather than the total sleep time. So, we know we're going to capture some time where a person is awake, where we don't have sleep apnea events, and that can be a big amount of time in people with insomnia, poor sleep efficiency. And as a result of that, it can lead to an underestimation of the apnea-hypopnea index. That's really important for people to understand that that means we can end up with a false negative home sleep apnea test, or it can put them in a category of lower severity than what they actually have. And so, if you get a home sleep study report back that's negative for sleep apnea and you remain concerned, you need to go on to do an in-lab study, where about twenty to fifty percent of people will go on to have a positive in-lab study. You can also get false positives with home sleep apnea tests too, and so ideally, we should only be doing home sleep apnea tests in people that are at high risk of having obstructive sleep apnea to decrease our chance of false positive study. When we get that sleep study report, what's important to take a look at? So the main number that we look at currently is the apnea-hypopnea index. The number of apneas, which are full obstructions in that upper airway, or hypopneas, partial obstructions in the upper airway where either there's an oxygen desaturation or an arousal associated with that. Less than five is considered to be normal. Anything five or more gives them a diagnosis of obstructive sleep apnea, and then we stratify them based on the AHI. But it's important to take a look at more than just the apnea-hypopnea index. And while my eyes too on various reports like echocardiograms want to jump to the impression, it is important to take a look at that full report, see what their oxygen levels averaged and what they dipped down to. The arousal index, which is how many times a patient may have woken up briefly throughout the night. Take a look at the histogram, usually an image at the bottom of their report that shows what sleep fragmentation may have been like so that you can take that all in and make that decision. How important are these study findings, and is this a person that would benefit from treatment?  Dr Berkowitz: That's a fantastic overview of sleep studies and some of the highlights to look out for, even if we won't be understanding every detail as you would to know most importantly the caveats about home sleep testing having a fairly high percentage of false negative and false positive results. So being wary if our suspicion is high, and that test is normal or inconclusive to get an in-lab sleep study. And if our suspicion is low or maybe we haven't ordered the test and the patient has had it done elsewhere, and the history doesn't really match up to know that there are false positives on the home studies as well, and again, an in-lab study to settle the diagnosis. Is that right?  Dr Stahl: Yes.  Dr Berkowitz: Okay. Now, for most neurologists, probably if we diagnose OSA, we will be referring the patient to a sleep specialist like yourself for treatment. I think we're all familiar with CPAP and patients being on CPAP. Your article mentions a number of treatment modalities I admit I have not heard of before or maybe heard of in passing, acknowledging most general neurologists are not going to be prescribing or knowing with the nuance that you do as an expert how to decide which treatment a patient would most benefit from or most qualify for. So, can you just give us a broad overview, again, for the general neurologist acknowledging we might see a patient whose past medical history says OSA being treated with fill in the blank. What are the different treatment modalities, and how do you think, just so we can learn from you in broad brush strokes, about particular treatments for particular patients?  Dr Stahl: As you mentioned, most people are familiar with positive airway pressure or PAP therapy, and that does remain our most efficacious treatment. The way I explain it to patients is why PAP therapy is the most effective treatment is it's the only treatment that can take all of the tissues of that upper airway and open them up. Whereas all of our other treatments, we're going to target smaller spaces of that upper airway. So, our first option is if we can get somebody on PAP therapy, we know that that's going to be the best option for the majority. PAP therapy works by basically acting as an air splint to open up the air tissues. Know that masks are not interchangeable. There are masks that cover the nose and go over the nose and mouth and under the nose. Full face masks that cover the nose and mouth, they do typically require higher pressures, also tend to be less comfortable for a lot of patients as well. In addition to different PAP masks, there's different modalities of positive airway pressure therapy too. There are machines that auto-adjust, some that provide fixed pressure, bi-level PAP that provides a higher inspiratory pressure, lower expiratory pressure. Then outside of PAP therapy, there are, as you alluded to, a lot of options and more, continuing to come down the pipeline as well. Mandibular advancement devices or a form of oral appliances has been around for a while. This is device that somebody wears in their mouth. It's preferably customized for their teeth and titratable, meaning that they can make adjustments that pulls their mandible forward in relation to the maxilla in order to pull those tongue tissues further away from the back of the upper airway. That's ideally managed by a qualified sleep dentist or someone that specializes in oral appliance management. Other treatments include surgical options, including hypoglossal nerve stimulation, which is an implanted device that causes the tongue to protrude repetitively throughout their sleep period to hopefully open up the airspace. There's some other surgical options too that open up various places of the upper airway. There's a daytime treatment of obstructive sleep apnea, transoral neuromuscular electrical stimulation that changes the muscle fiber type of the tongue. And then there's some adjunctive treatments that can be helpful too, such as positional therapy, oral facial myofunctional therapy that helps a person breathe better through their nose and may help train the upper airway muscles.  Dr Berkowitz: Great. Well, that's a very helpful overview, and again, I refer our listeners to your article, which talks about all of those modalities in very comprehensive detail. So, Dr. Stahl, as we wrap up our conversation, you have a captive audience of neurologists and neurology trainees here. What would you like to leave us with that every neurologist should know about obstructive sleep apnea?  Dr Stahl: The most important, again, is for neurologists to know that obstructive sleep apnea is so common in your patient population, and it can have a significant negative impact on quality of life and health, including many neurologic conditions. And at the same time, obstructive sleep apnea is very treatable. We have so many options nowadays that we can usually get someone onto adequate treatment. And treatment has that potential to improve several neurologic symptoms and disorders, even at times when you don't think that there's an opportunity to improve symptoms such as say in, headache. So, neurologists really should be screening for signs and symptoms of obstructive sleep apnea, as well as considering testing in high-risk, potentially asymptomatic or minimally symptomatic patients.  Dr Berkowitz: That's a fantastic overview of some of the many pearls that you shared with us today, as well as in your article. So, thank you so much again. Today, I've been interviewing Dr. Stephanie Stahl about her article on obstructive sleep apnea. This article appears in the August 2026 Continuum issue on neurology of sleep. Be sure to check out Continuum Audio episodes from this and other issues. And thank you so much to our listeners for joining today, and thank you again, Dr. Stahl.  Dr Stahl: Thank you again for having me.  Dr Monteith: This is Dr. Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.  

"One day is a mental marathon, and so it is very difficult for the brain to be the best version of itself for everything. You don't have to be— your average is good for average experiences. Your best is needed for your most important experiences." —Dr. Izzy Justice The 10 Hertz brain state is the frequency neuroscientist Dr. Izzy Justice says separates your best decisions from your worst ones — and it's hiding in plain sight, 10 to 20 seconds away at any moment. After running more than 18,000 wireless EEG brain scans on everyone from NBA players to executives to trauma survivors, Dr. Justice discovered that peak focus, deep empathy, and total presence all cluster around the same low-noise brainwave frequency: roughly 10 Hertz. In this conversation with host Justine Reichman, Dr. Justice explains why wireless EEG technology changed how we understand the brain, how trauma physically "polarizes" specific neurons decades after the event, and why the fix isn't suppressing the memory but giving it a final chapter. He also walks through three practical neurohacks — techniques that take seconds, require no equipment, and can be used mid-conversation, mid-pitch, or mid-panic. This episode is for anyone who has ever felt foggy under pressure, reactive in a stressful moment, or unsure why their body remembers things their mind has tried to forget. Key Takeaways: Peak human performance and full sensory presence both happen near 10 Hertz, a measurably low-noise brain frequency — not a mindset or personality trait. Trauma creates highly "polarized" neurons that stay dormant until a matching sound, smell, or sensation reactivates them, sometimes decades later. You don't need to be your best self all day — reserving these techniques for one or two high-stakes moments daily is enough. The 10-10 technique (count fast to 10, then slow back to one) shifts brain state in about 20 seconds using nothing but your mind. The palm-tap technique and 4-2-8 breathing pattern each take 10 to 20 seconds and can be done anywhere, anytime. Healing trauma isn't about erasing the memory — it's about writing a final chapter where the experience serves a purpose. Listen to the full conversation and subscribe to Essential Ingredients so you never miss an episode:  https://tinyurl.com/Essential-Ingredients-Podcast  Meet Izzy:  Dr. Izzy Justice is the Chief Neuroscience Officer at Neuro580, a groundbreaking company at the forefront of human performance, sports psychology, and mental training. As a pioneering Sports Neuroscientist, he has certified over 300 coaches worldwide and has worked with elite athletes across multiple sports, many of whom have gone on to win Major Championships and Olympic Medals. Dr. Justice is the creator of Neurohacks-rapid, science-backed techniques that remove mental distractions, boost focus under pressure, and help athletes access the flow state in real time. With over 18,000 EEG-based functional brain scans conducted during live performance, he brings unmatched insight into golf neuroscience, mental toughness, and brainwave management for peak performance. As a consultant and executive coach, Dr. Justice has helped over 30 CEOs and dozens of Chief People Officers unlock leadership mindset, drive business performance, and build cultures of resilience through neuroscience. From Zambia, Africa, and based in the U.S. for the past 40 years, Dr. Justice is the Best-Selling Author of 10 Books, including his latest, Your Brain Swings Every Club (Foreword by Brad Faxon), which bridges the gap between golf focus techniques, emotional control, and personal mastery. Website LinkedIn Instagram  X YouTube Connet with Neuro580:  Website LinkedIn Instagram  TikTok Connect with NextGen Purpose: Website Facebook Instagram LinkedIn YouTube Podcast Chapters: 01:03 Meet Dr. Izzy Justice: From Boardroom to Brainwaves 04:10 How Wireless EEG Technology Changed Brain Science 08:32 Redefining Trauma as a Neuroscience Problem 14:03 The Mothers Who Turned Grief Into Purpose 19:55 The 10 Hertz Scale: Why Less Brain Noise Wins 28:22 The 10-10 Neurohack for Instant Focus 30:26 The Palm Tap: A 15-Second Calm Reset 33:00 The 4-2-8 Breathing Technique 41:10 What We'll Understand About the Brain Next 42:45 Key Takeaway: Longevity Starts With Your Brain  Resources:  Book Life Explained: Chasing 10Hz by Dr. Izzy Justice  THE PRIMES  ✨ You're more capable than you have ever been, and somehow more invisible than ever. You keep handing out advice you do not take yourself. You keep saying 'after this next thing' to your own life, and the people around you have no idea because, from the outside, everything looks fine— that is exactly what The Primes was built for.

Episode 189: Travis Hahler & his book, Rethink Resistance: Embracing Neuroscience to Lead Transformational ChangeABOUT TRAVISTravis transforms how Fortune 500 companies navigate change by revealing a startling truth: Resistance isn't rebellion—it's biology. As Senior Director of Global Strategy and Transformation at Salesforce, and Founder of The Neurological Nomad, Travis brings an unprecedented fusion of neuroscience and business acumen to organizational transformation. His unique journey conducting EEG research in Denmark, studying neuropsychology at Harvard, earning an MBA, and leading change at Google, Salesforce, and others, makes him a unique transformation expert who can explain why your amygdala sabotages your strategic plan and why you can blame everything on your basil ganglia. Over fifteen years, Travis has guided more than one hundred companies through successful transformations, earning him the nickname Resistance Fortune Teller for his uncanny ability to predict where change efforts will fail. His signature keynote, The Neuroscience of Change, has reached over 25,000 leaders across 150 global events, consistently delivering that aha moment when executives finally understand why 70 percent of transformations fail to achieve their goals. CONVERSATION HIGHLIGHTS• Travis introduces his background blending neuropsychology, neuroscience, and business transformation.• The misconception that resistance is rebellion and how to reframe it as a natural protective response.• Six neurological barriers affecting change: basal ganglia routines, overloading prefrontal cortex, exclusion pain, ambiguity, threat responses, and loss.• Practical leadership strategies aligned with brain science to navigate each barrier.• The importance of emotional regulation and empathy in parenting and leadership inspired by neuroscience.• How neuroscience understanding helps to normalize resistance, reducing ego threats for leaders.• The evolution of Travis's work from consulting to public speaking and authoring the book "Rethink Resistance."• The role of language, poised by Brené Brown's insights, in shaping emotional experiences and understanding.• The future focus on applying neuroscience to AI transformations, emphasizing mindset shifts over tools.The MAIN QUESTION for you that comes out of my conversation with Travis is, To avoid the adverse and unfortunate effects of impulsive emotion, how much do you seek to understand the science of your mind when it comes to your leadership? FIND TRAVIS• Website: http://www.travishahler.com/• Instagram: https://www.instagram.com/theneurologicalnomad/• LinkedIn: https://www.linkedin.com/in/travisdhahler/• Link to order the book: https://linktr.ee/theneurologicalnomadFULL LINKEDIN ARTICLE: CHAPTERS00:00 - The Book Leads Podcast - Travis Hahler00:57- Introduction & Bio03:51 - Who are you today? Can you provide more information about your work?10:36 - What did you path to today look like?32:57 - How does the work you're doing today reconcile to who you were as a child?40:39 - What do you consider your superpower?43:54 - What does leadership mean to you?48:27 - Can you introduce us to the book we're discussing?55:46 - How did you structure the book to take the reader on their journey?01:02:28 - What's next for your writing?01:04:39 - What's changed in you in the process of writing this book?01:07:10 - What book has inspired you?01:12:31 - What are you up to these days? (A way for guests to share and market their projects and work.)This series has become my Masterclass In Humanity. I'd love for you to join me and see what you take away from these conversations.Learn more about The Book Leads and listen to past episodes:Watch on YouTubeWatch on YouTube MusicListen on SpotifyListen on Apple PodcastsRead About The Book Leads – Blog PostFor more great content, check out the catalog for my newsletter Last Week's Leadership Lessons, if you haven't already!

durée : 00:59:58 - par : Nathalie Piolé - La playlist jazz de Nathalie Piolé. - équipe : Emmanuelle Lacaze, Fabien Fleurat Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

If you enjoy this episode, we're sure you will enjoy more content like this on The Occult Rejects.  In fact, we have curated playlists on occult topics like grimoires, esoteric concepts and phenomena, occult history, analyzing true crime and cults with an occult lens, Para politics, and occultism in music. Whether you enjoy consuming your content visually or via audio, we've got you covered - and it will always be provided free of charge.  So, if you enjoy what we do and want to support our work of providing accessible, free content on various platforms, please consider making a donation to the links provided below.  Thank you and enjoy the episode!Links For The Occult Rejectshttps://linktr.ee/theoccultrejectsOccult Research Institutehttps://www.occultresearchinstitute.org/Substackhttps://substack.com/@theoccultrejects?r=7auau0&utm_campaign=profile&utm_medium=profile-pageCash Apphttps://cash.app/$theoccultrejectsVenmo@TheOccultRejectsBuy Me A Coffeebuymeacoffee.com/TheOccultRejectsPatreonhttps://www.patreon.com/TheOccultRejectsDarkness, Sensory Deprivation, Caves, and Visionary ConditionsUstinova, Yulia. Caves and the Ancient Greek Mind: Descending Underground in the Search for Ultimate Truth. Oxford: Oxford University Press, 2009.Use for: caves, descent, darkness, ancient Greek revelation, incubation, inspired prophecy, and altered states in underground sacred settings.Lewis-Williams, David. The Mind in the Cave: Consciousness and the Origins of Art. London: Thames & Hudson, 2002.Use for: caves, prehistoric imagery, altered consciousness, visual phenomena, and symbolic environments. Use carefully because some interpretations of prehistoric religion remain debated.Eliade, Mircea. The Sacred and the Profane: The Nature of Religion. New York: Harcourt, 1959.Use for: sacred space, threshold, the difference between sacred and profane space, and the way religious environments reorganize orientation and meaning.Zuckerman, Marvin, and Nathan Cohen. “Sources of Reports of Visual and Auditory Sensations in Perceptual-Isolation Experiments.” Psychological Bulletin 61, no. 1, 1964: 1–20.Use for: sensory deprivation, perceptual isolation, visual/auditory sensations, and internally generated experiences under reduced stimulation.Wackermann, Jiří, Peter Pütz, and Carsten Allefeld. “Ganzfeld-Induced Hallucinatory Experience, Its Phenomenology and Cerebral Electrophysiology.” Cortex 44, no. 10, 2008: 1364–1378.Use for: Ganzfeld states, reduced/uniform sensory fields, pseudo-hallucinatory imagery, altered perception, and EEG findings.Metzger, Wolfgang. “Optische Untersuchungen am Ganzfeld.” Psychologische Forschung 13, 1930: 6–29.Use for: early Ganzfeld research and the effect of homogeneous visual fields on perception.Shenyan, O., et al. “Visual Hallucinations Induced by Ganzflicker and Ganzfeld Differ in Frequency, Complexity, and Content.” Scientific Reports 14, 2024.Use for: modern comparison between Ganzfeld and flicker-induced visual phenomena. Useful if connecting this episode back to the earlier flicker-light show.Candlelight, Firelight, Sacred Atmosphere, and the Agency of LightBille, Mikkel, and Tim Flohr Sørensen. “An Anthropology of Luminosity: The Agency of Light.” Journal of Material Culture 12, no. 3, 2007: 263–284.Use for: light as a social, material, emotional, and cultural agent; how light shapes atmosphere, social meaning, and movement.Bille, Mikkel, and Tim Flohr Sørensen, eds. Elements of Architecture: Assembling Archaeology, Atmosphere and the Performance of Building Spaces. London: Routledge, 2016.Use for: architecture, atmosphere, materiality, embodied space, and how built environments shape experience.Pallasmaa, Juhani. The Eyes of the Skin: Architecture and the Senses. Chichester: Wiley, 1996; later editions.Use for: architecture as multisensory experience, not just visual design; helpful for sacred architecture, embodied space, and sensory atmosphere.Barrie, Thomas. “Sacred Space and the Mediating Roles of Architecture.” European Review 20, no. 4, 2012: 505–514.Use for: sacred architecture as a mediating threshold between ordinary and sacred worlds.Kieckhefer, Richard. Theology in Stone: Church Architecture from Byzantium to Berkeley. Oxford: Oxford University Press, 2004.Use for: Christian sacred architecture, spatial theology, light, ritual orientation, and the way buildings teach belief through space.Do, Michael T. H. “Melanopsin and the Intrinsically Photosensitive Retinal Ganglion Cells: Biophysics to Behavior.” Neuron 104, no. 2, 2019: 205–226.Use for: melanopsin, intrinsically photosensitive retinal ganglion cells, non-image-forming vision, and the biological effects of light beyond ordinary sight.Hattar, Samer, H. W. Liao, Motoharu Takao, David M. Berson, and King-Wai Yau. “Melanopsin-Containing Retinal Ganglion Cells: Architecture, Projections, and Intrinsic Photosensitivity.” Science 295, no. 5557, 2002: 1065–1070.Use for: retinal ganglion cells that detect light for non-image-forming functions, including circadian-related pathways.Blume, Christine, Corrado Garbazza, and Manuel Spitschan. “Effects of Light on Human Circadian Rhythms, Sleep and Mood.” Somnologie 23, 2019: 147–156.Use for: light, circadian rhythms, sleep, mood, and why sunlight, darkness, dawn, and dusk matter biologically.Cajochen, Christian. “Alerting Effects of Light.” Sleep Medicine Reviews 11, no. 6, 2007: 453–464.Use for: light's alerting effects beyond image-forming vision.Stained Glass, Religious Light, and Visual TheologyBinski, Paul. Gothic Wonder: Art, Artifice, and the Decorated Style, 1290–1350. New Haven: Yale University Press, 2014.Use for: Gothic visual culture, sacred display, ornament, and the emotional force of medieval religious space.Camille, Michael. Gothic Art: Glorious Visions. New York: Harry N. Abrams, 1996.Use for: Gothic imagery, religious seeing, visual devotion, and sacred art as visionary environment.Kessler, Herbert L. Seeing Medieval Art. Peterborough, Ontario: Broadview Press, 2004.Use for: medieval Christian theories of seeing, devotional image use, sacred art, and vision as religious practice.Hamburger, Jeffrey F. The Visual and the Visionary: Art and Female Spirituality in Late Medieval Germany. New York: Zone Books, 1998.Use for: visionary art, devotional seeing, mystical imagery, and the relationship between images and religious experience.Freedberg, David. The Power of Images: Studies in the History and Theory of Response. Chicago: University of Chicago Press, 1989.Use for: why images provoke emotion, devotion, fear, desire, reverence, and acts of ritual engagement.Scrying, Black Mirrors, Crystal Gazing, and Reflective VisionCaputo, Giovanni B. “Strange-Face-in-the-Mirror Illusion.” Perception 39, no. 7, 2010: 1007–1008.Use for: mirror-gazing under low light, face distortion, visual instability, and apparitional perception.Caputo, Giovanni B. “Apparitional Experiences of New Faces and Dissociation of Self-Identity During Mirror Gazing.” Perceptual and Motor Skills 110, no. 3, 2010: 1125–1138.Use for: mirror-gazing, dissociation, altered self-recognition, and strange-face experiences.Caputo, Giovanni B. “Strange-Face Illusions During Inter-Subjective Gazing.” Consciousness and Cognition 22, no. 1, 2013: 324–329.Use for: prolonged eye-to-eye gazing, face alteration, dissociative effects, and interpersonal gaze phenomena.Caputo, Giovanni B. “Visual Perception During Mirror-Gazing at One's Own Face in Patients with Depression.” The Scientific World Journal, 2014.Use for: mirror-gazing research and altered self-perception. Useful for grounding black mirror and psychomanteum discussion, but do not overgeneralize.Moody, Raymond A., with Paul Perry. Reunions: Visionary Encounters with Departed Loved Ones. New York: Villard, 1993.Use for: modern psychomanteum practice, mirror-gazing, grief, and visionary encounters. Use cautiously; this is experiential/parapsychological material, not mainstream neuroscience.Roll, William G. “Psychomanteum Research: A Pilot Study.” Journal of Near-Death Studies 22, no. 4, 2004: 251–270.Use for: psychomanteum research, bereavement visions, mirror-gazing, and altered perception. Use cautiously.Northcote, Thomas. “Scrying.” In The Encyclopedia of Occultism and Parapsychology, edited by J. Gordon Melton. Detroit: Gale, various editions.Use for: general historical overview of scrying traditions, crystal gazing, mirror gazing, and divinatory seeing.Agrippa, Heinrich Cornelius. Three Books of Occult Philosophy. Translated by James Freake; edited and annotated by Donald Tyson. St. Paul, MN: Llewellyn, 1993.Use for: Renaissance magical imagination, correspondences, planetary symbols, spirits, and visual/ritual operations.Barrett, Francis. The Magus. London, 1801.Use for: later ceremonial magic, mirrors, spirits, correspondences, and visual ritual imagination. Use historically, not as scientific evidence.Magical Gaze, Concentration, Visualization, and Ceremonial PracticeCrowley, Aleister. Liber E vel Exercitiorum. In The Equinox.Use for: concentration, posture, breath, mental discipline, and the training of attention as a magical foundation.Crowley, Aleister. Magick: Liber ABA, Book 4. York Beach, ME: Samuel Weiser, various editions.Use for: ceremonial magic, concentration, visualization, ritual method, symbols, and disciplined magical practice.Regardie, Israel. The Golden Dawn. St. Paul, MN: Llewellyn, variousAlso want to remind people about the website, if you're into reading we have tons of information by multiple contributors, and we got t-shirts up on the site if you're interested. Fun fact, the art is all based on the eyeball. 

Photo by Zac Taheriyan on Unsplash Published 10 August 2026 e564 with Michael, Andy and Michael – a spider filled episode with AdTech and lifesaving robotic implications, VR Mario Kart, quantum lawn mowing, identity management and a whole lot more! Michael, Andy and Michael begin the episode with Spider-Man showing up in an unexpected place – a BMW infotainment system!  The negative reactions from the articles and cohosts were not surprising.  The team have discussed ads you don't want showing up where you don't want them – like on automotive windshields, in AR, and more – see e481 from 2024 in the links below for more on this. The team shifts to a more enjoyable driving experience, where Andy describes what he did to enable a VR version of Mario Kart.  Next up – a reflection on 30 years of Quake with an anniversary release.  Then, appealing to the team's sensibilities on mowing lawns and penchant for NP quantum problems, a lawn mowing optimization game from Pudding.   Switching from software to hardware, the cohosts take a look at a surprising smaller than expected device called the Octopus 16 which measures EEG brain signals to allow the user to control a computer.  See the show notes below for the original box for the Emotiv headset from the July 2015 kickstarter. Then, the titular post for this show, a new robot based on nature for rescuing people who are drowning.  The inspiration for this robot was a fishing spider who walks on water to capture its prey.  Your show notes thankfully do not include pictures of such spiders, though if you click through to the Arxiv paper, there is a picture, so consider yourself warned.  While not discussed in this episode, Dr. Kate Darling's book The New Breed: What Our History with Animals Reveals about Our Future with Robots explores social and ethical themes on robotics that fit nicely into this theme.  Michael M had a chance to hear her speak at Duke earlier this year and an article about that talk is included in the notes below. Rounding out the show, the team wraps up with an identity service from Meta called Facebook Verified.  This free service is intended to help identify when a person is a human and distinguish from AI agents.  The cohosts shared thoughts about this topic and the service before the recording time was exhausted. Aside from spiders, what other robotic form factors based on the animal and insect kingdom would you want to see?  Have your bots

Sound Healing with David Gibson Healing Modes: Finding Frequencies and Resonating What Is Right David Gibson explains sound-healing methods for identifying physical, emotional, mental, and spiritual frequencies, then explores how frequency sweeps, intuition, muscle testing, pendulums, voice analysis, binaural beats, phase cancellation, homeopathy-style resonance, and Source connection may be used in healing work. Sound Healing Center, Training, and the Episode's Focus In this Sound Healing — Healing Modes episode, David Gibson introduces the Sound Healing Center's broader work, including the Institute, Sound Healing Store, Sound Therapy Center, Sound Healing Research Foundation, Medical Sound Association, and Sound Education Association. He also shares updates about programs, an open house, certificate training, recording classes, and voice-analysis software. The central focus of the episode is how to find the frequency of a body part, organ, emotional issue, disease pattern, or healthy state, and then what to do with that frequency once it is identified. The transcript notes that medical and healing claims are preserved as the host's statements and should be reviewed before being presented as health guidance. Two Healing Paths: What Is Wrong and What Is Right David frames the teaching around two major approaches: finding the frequency of what is “wrong” and working to disrupt it, or finding the frequency of what is “right” and resonating that healthy state. He gives examples such as cancer, stuck emotion, chronic pain, and organ resonance to show how a practitioner might either break up a problematic vibration or strengthen the frequency of a healthy body part. Throughout the episode, he returns to the idea that stable, consistent sound, positive intention, and resonance may help bring a system back toward balance. Frequency Sweeps, Intuition, Muscle Testing, and Pendulums David describes several ways to locate frequencies. One method is a frequency sweep, where a person moves the voice up and down on a vowel until a body area vibrates most strongly. For parts of the body that cannot easily be felt, he suggests intuitive listening, where the right tone may arrive as a knowing, inner sound, or subtle signal. He also discusses muscle testing, balance testing, listening for chills, using a pendulum to narrow frequency ranges, and playing the twelve notes while observing which note strengthens the body. Timbre, Vowels, Musical Flow, and Frequency References The episode expands from single tones into timbre, which David describes as the combination of frequencies that make up an organ, cell, or body system. He explains that organs may have multiple layers of frequency, including material, cellular, atomic, photon, electromagnetic, and quantum levels, and he compares these combinations to vowel sounds. He also introduces the idea of listening for the “song” or musical flow of the nervous, circulatory, or digestive system. David mentions frequency charts, Rife-related sets, Qigong organ notes, and other references, while acknowledging that different sources often disagree. Devices, Voice Analysis, and Scientific Measurement David also discusses device-based methods for assessing or exploring frequency. He mentions galvanic skin response, HeartMath, voice-analysis tools, NES, QXCI, Zyto, Asyra, GDV/Kirlian photography, EKG, EEG, Chinese pulse reading, microscopy, spectroscopy, and MRI-related measurement. His own voice-analysis program is described as mapping notes connected to organs and physical or emotional issues, while also requiring interpretation to determine whether a frequency is excessive or deficient. This section presents technology as another pathway for exploring resonance, coherence, and body-system response. Breaking Up Imbalance and Transforming Chaos Once a problematic frequency is found, David outlines several possible methods for working with it. He describes a homeopathy-style approach in which a low dose of the problem frequency may bring the issue to the body's attention, as well as techniques that match, meet, disrupt, or transform chaotic vibrations. He discusses binaural-beat-like differences, going slightly above and below a target frequency, crystal bowls, tone generators, destructive resonance, phase cancellation, reciprocal frequencies, and the use of chaotic sounds such as rattles or white noise to break up stuck energy. He also connects these ideas to emotional release, such as transforming painful relationship energy into peace. Resonating Health, Balance, and Source David ultimately emphasizes resonating what is right as the preferred direction. This includes singing, breathing, or playing the healthy frequency of a body part, balancing missing or excessive frequencies, working with a home note or brainwave rhythm, and using sound to support states such as sleep, creativity, presence, focus, and bliss. He closes by moving beyond specific frequencies into higher vibration, gratitude, joy, universal love, and Source, saying that connection to Source allows spirit to know what the body needs. The episode ends with an affirmation-like closing, sustained tones, repeated healing phrases, and music fading out.

Get 10% off your first Leela Quantum order with the code NatalieJill at checkout  at https://midlifeconversations.com/leela    Try Quantum Upgrade completely free for 15 days—no credit card required. Use code NATALIEJILL at checkout on https://quantumupgrade.io/start  What if the headache you can't explain, the brain fog that won't lift, or the exhaustion no lab test can find has been sitting in the walls of your own home this whole time? This week Natalie sits down with Dr. Henz, a neuroscientist and EEG researcher, and Philipp Von Holtzendorff-Fehling, a former T-Mobile executive turned tech founder, for a conversation that goes places most health podcasts never go. Dr. Henz shares her own story of getting mysteriously ill in a tech-filled office, including a decade-long fertility struggle doctors couldn't explain, and how she eventually connected it to the invisible electromagnetic fields surrounding her every day. Philipp pulls back the curtain on his years inside the telecom industry, why he walked away from a corporate career to dig into this question full time, and what his team found after testing dozens of products claiming to protect you from EMF exposure (spoiler: most of them do nothing, and a couple made things worse). You'll hear about the internal lab research Dr. Henz and Philipp have compiled using high-density EEG technology, what happens to brain wave activity during something as simple as a phone call, and their perspective on why getting closer to nature and natural frequencies may matter more than we think. This one will change how you think about your phone, your WiFi router, and the space you sleep in tonight. WE GO DEEP ON:  Dr. Henz's personal health crisis and the invisible cause behind it Why your body has no built-in sensor for electromagnetic exposure What high-density EEG reveals about brain activity and stress frequencies Philipp's journey from T-Mobile executive to EMF researcher The internal lab data behind Quantum Upgrade's technology What happened when they tested 70+ EMF "protection" products Simple, low-effort shifts you can make starting tonight Catch the full episode on YOUTUBE HERE: https://bit.ly/MidlifeConversationsYouTube   Episode Links: See Natalie's brain scan results https://www.midlifeconversations.com/nataliejillresults/ Leela Quantum: Get 10% off your first Leela Quantum order with the code NatalieJill at checkout  at https://midlifeconversations.com/leela    Quantum Upgrade: Try Quantum Upgrade completely free for 15 days—no credit card required. Use code NATALIEJILL at checkout on https://quantumupgrade.io/start    Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.  

Some of the best conversations don't happen on stage—they happen after the conference.Originally recorded following a previous Suisun Summit, this NeuroNoodle panel captures the discussions that were shaping the future of neurofeedback: biomarkers, QEEG, trauma, autism, ADHD, licensing, ethics, and why many clinicians are moving beyond diagnostic labels toward understanding brain function.With the 2026 Suisun Neuroscience Summit just around the corner, it's fascinating to revisit these conversations and see how many of these ideas continue to influence clinical practice today.

Why are you waking up in the middle of the night, and why is it so hard to fall back asleep? Andrea talks with Dr. Michael Breus, known as The Sleep Doctor, about the biology behind night wakings, the common sleep advice that backfires, and the practical shifts that can help. From melatonin and sleep meds to caffeine, alcohol, and inconsistent wake times, this episode helps you make sense of what your body is doing at night so you can work with it instead of against it. Tune in, take action, and start sleeping better tonight. ✨ Learn more about Dr. Michael Breus and Discover Your Chronotype Quiz: https://sleepdoctor.com/whatresonatesRecorded: May 12th, 2026Episode Highlights: 00:00 - Lucid Dreaming Teaser00:34 - Podcast Welcome Intro01:06 - Meet Dr Michael Breus02:35 - Why Sleep Changes Life05:09 - Sleep Flexibility Quality06:19 - Wake Time Consistency11:17 - Aging Sleep Myths14:01 - Chronotypes and Genetics16:43 - Why You Wake 1 to 3 AM18:42 - Don't Pee Don't Clock22:27 - 4-7-8 Breathing Protocol26:22 - Relax Reset Positivity30:04 - Calming Night Worries31:02 - Power Down Hour Routine34:56 - Sleep Environment Gear37:53 - Sleep Masks That Work40:08 - Exercise Timing Rules42:00 - Meditation And Sleep43:56 - Dreams And Lucid States48:15 - Supplements And Bloodwork50:17 - Melatonin Myths And Risks54:43 - Sleep Meds Safety57:51 - Caffeine Alcohol Cutoffs01:00:50 - Wrap Up And FarewellSleep Doctor At Home SleepTest (SleepDoctor.com)The Sleep Doctor At-Home Sleep Test provides clinical-level sleep analysis from the comfort of your own bed. Using two simple sensors and a connected app, users receive personalized results reviewed by a licensed provider in under a week.Orion Cooling Mattress Pad (orionsleep.com)The Orion Cooling Mattress Pad uses active temperature regulation technology to maintain an optimal sleep environment and reduce overheating throughout the night. It offers smart-bed-level cooling benefits at a more accessible price point.NextSense Earbuds (nextsense.io)These ear buds use EEG sensors to detect deep sleep and deliver gentle sound pulses to enhance restorative sleep.Channel Your Divine Self, a twelve-week live course where you build a direct, grounded relationship with your own inner guidance, alongside the Emissaries of Light. The waitlist is open now, and you'll be the first to know when registration begins. Join the waitlist: https://mainstream-reiki.kit.com/cydswaitlistAndrea's Links: https://beacons.ai/andrea_kennedyAndrea's Reiki Business Success Course:https://www.mainstreamreiki.com/reiki-business-success-courseVisit our websiteVisit our Amazon Shop  Sponsored by The Mainstream Reiki Community https://members.mainstreamreiki.com/HealthyLine offers revolutionary PEMF  and far-infrared mats. Get 10% off and free shipping in the continental US with code "Mainstream10FS". What Resonates? is produced by Twisted Spur MediaAndrea may earn money through Amazon for qualifying purchases.Disclaimer: The views and opinions expressed in this program do not  reflect those of the podcast or anyone affiliated with its production. This program is presented for entertainment purposes only. The utilization of the information provided is at the listener's own discretion.

Can technology help us tune into our inner guidance and tap into deeper states of awareness? In this episode, we sit down with transdisciplinary artist and futurist Seneida Ng and biofeedback sound developer Jason Snell. Together, they are pioneering new ways to translate neural activity and physiological signals into immersive music—creating a direct feedback loop between the human body, brainwaves, and sound.  From ancient drumming rituals and trance states to cutting-edge EEG neurofeedback and biofeedback sound baths, discover how sonifying our internal frequencies can help lower anxiety, deepen empathy, and unlock our natural intuition. 

Leigh Ann welcomes Christine Lee of Cereset Mission Viejo for a conversation on brain optimization, trauma, nervous system regulation, sleep, and what it means to let the brain rebalance itself. Christine shares her personal story of living with stress, insomnia, trauma, and deep nervous system dysregulation before discovering Cereset as a client and eventually purchasing the practice herself. She explains how Cereset uses read-only EEG sensors and AI-generated acoustic tones to create a “brain echo,” allowing the brain to hear itself and identify where it may be energetically out of balance. Leigh Ann and Christine discuss the difference between supporting the brain's “hardware” and doing deeper emotional “software” work, especially for clients whose systems feel too hijacked for meditation, breathwork, journaling, or somatic practices to land. They also explore how Cereset may support people navigating trauma, insomnia, concussion, mood dysregulation, medication tapering goals, chronic illness, cancer, mold, mast cell activation, and nervous system overwhelm. Product Discount Codes + LinksHoolest: Website (Discount Code: THEACCRESCENT10)Froya Hair Care: Website (Link gives 10% off)Herbal Face Food: Website (Discount Code: LAL30)Guest InfoCereset Mission Viejo - Website (mention this episode for a free discovery and intake call!)Cereset Mission Viejo - FacebookRelated EpisodesPodcast Ep. 247: Dr. Aimie Apigian - The Biology of TraumaPodcast Ep. 181: Danielle Palmer - How Injury and Trauma Disrupt Your Body's Electrical Flow and The Power of Frequency Therapy To Restore ItWork w/Leigh AnnLearn: What is EVOX Therapy?Book: Schedule a Session or FREE Discovery CallMembership: What is The Healing Alchemy MembershipConnect w/Me & Learn MoreWebsiteInstagramTiktokYoutube

Jay Gunkelman has read more than half a million brain scans — so when Joshua Moore hands him a blind EEG with no history and no chart, it takes about 70 seconds. The brain in front of him is drifting into stage-one drowsiness with the eyes still open, and Jay calls it cold: a primary disorder of vigilance. Host Pete Jansons walks through it with him frame by frame — eyes open and eyes closed — so you can watch the read happen in real time.Along the way: why arousal and vigilance are NOT the same thing (and why an amphetamine is the wrong tool), what "highway hypnosis" actually is at the level of the EEG, why your Oura ring can flag hypoxia but can't tell you if it's central or obstructive, and the lost art of reading 100 paper EEGs a day with a pencil so you don't get paper cuts. Plus Joshua Moore's Brain Bar intro to QEEG phenotypes.

Duration: 1 hr In this episode of Bright Spots in Healthcare, host Eric Glazer brings together leaders from Johns Hopkins Medicine, Northwell Health, WVU Medicine, and TytoCare to explore one of healthcare's biggest challenges: how to move beyond isolated AI pilots and operationalize AI in ways that genuinely improve specialty care. While AI continues to dominate headlines, the organizations making the greatest progress aren't simply adopting more technology. They're redesigning workflows, strengthening governance, extending specialist expertise, and embedding AI into clinical operations in ways that improve patient access while reducing burden on clinicians. This discussion explores what it really takes to scale AI across complex health systems, from executive strategy and governance to workflow redesign, remote examinations, ambient AI, and extending specialty expertise into rural and underserved communities. Our guests include: Rebecca Canino, MBA, Executive Director, Office of Telemedicine, Johns Hopkins Medicine Kristin Myers, Executive Vice President & Chief Digital Officer, Northwell Health Sharda Udassi, MD, Professor, Pediatric Hospital Medicine Division & Associate Chief Quality Officer, WVU Medicine Greg Orr, Chief Operating Officer, TytoCare Together, they explore: Why successful AI initiatives begin with operational transformation—not technology deployment How leading health systems are embedding AI into existing clinical workflows instead of creating new ones What governance looks like when organizations are scaling AI responsibly How remote examinations and AI are helping extend scarce specialty expertise into rural and community settings Practical examples of AI improving diabetic retinopathy screening, patient navigation, scheduling, EEG interpretation, and specialty access Why redesigning care delivery—not simply adding digital tools—is becoming the key to sustainable AI adoption Where healthcare leaders see the next generation of AI creating measurable impact for clinicians and patients alike. Whether you're leading digital transformation, telehealth, clinical operations, or AI strategy, this episode offers practical lessons from organizations moving beyond experimentation and successfully scaling AI across specialty care. Panelist Bios: https://www.brightspotsinhealthcare.com/events/scaling-ai-enabled-remote-specialty-care-from-innovation-to-operational-performance/ Download the Episode Guide: Get key takeaways and expert highlights to help you apply lessons from the episode. Download guide: https://www.brightspotsinhealthcare.com/wp-content/uploads/2026/07/Episode-Guide-Bright-Spots-in-Health-Care-TytoCare-07-15-26.pdf  Key Insights Summary: Find key insights from the discussion, guest takeaways, and detailed moderator notes captured by Eric during the conversation, https://www.brightspotsinhealthcare.com/wp-content/uploads/2026/07/Key-Insights-Summary-Bright-Spots-07-15-26.pdf   Thank You to Our Episode Partner, TytoCare: TytoCare is helping health systems rethink how specialty care is delivered beyond the traditional walls of the hospital and clinic. Through its AI-enabled, FDA-cleared remote examination platform, TytoCare equips clinicians with clinical-grade exam data from virtually anywhere, enabling more informed decision-making than video visits alone. By combining guided remote examinations with AI-assisted workflows, TytoCare helps provider organizations improve access to specialty care, optimize clinician capacity, strengthen virtual care models, and create more connected patient experiences. As health systems look to scale AI responsibly, TytoCare is helping turn innovation into operational performance. Schedule a Meeting with a Senior Leader at TytoCare: Interested in learning how leading health systems are scaling remote specialty care?  To connect with Greg Orr or another member of the TytoCare leadership team, contact show producer Jessica Tenzer at jtenzer@brightspotsventures.com to schedule a conversation. About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.

Dear readers, I've been a sceptic for too long. It's easy to be sceptical as a psychiatrist—the flowers will be lour'd upon you! I've been using Graymatter's Health PRISM EEG-fMRI neurofeedback system for a few years, it's true. There are EEG leads on there. I saw a lot of EEG-related technology in Beijing. It's possible I'm looking at an EEG in this very photo from my hotel room in China, below:But have I been measuring the brain with EEG regularly? Well, no, again! I've been content with my fancy fMRI scans alone, for SAINT, and giant brain healing magnets at set frequencies, like deep TMS with SWIFT.There are even videos of me talking about TMS, like this one below, with friends like Colleen Hanlon from BrainsWay, and heroic patients who chose to speak publicly, too.But one thing I haven't routinely done is measure the brain itself as part of clinical care, as companies like Firefly Neuroscience are making possible. That may need to change, is the outcome in my personal brain as a result of this interview. I speak, at length, with Dave Decaprio, their president and COO.The EVOKE system provides multimodal analysis of brain function, including Quantitative EEG and Event-Related Potentials. From the Firefly website:At Firefly Neuroscience, our technology is built to measure and interpret brain function in a clinically meaningful way. The Evoke™ system combines quantitative EEG (qEEG) and event-related potentials (ERP) to capture both baseline brain activity and cognitive response during structured tasks.This data is analyzed against a proprietary normative database of over 191,000 EEG and ERP sessions, allowing clinicians to evaluate patterns relative to age-matched expectations and track changes over time. The result is a structured, interpretable view of brain function that can be used alongside clinical evaluation to support earlier insight, more informed treatment decisions, and a clearer understanding of patient progress.I haven't used it in clinical practice yet, but Dave makes a compelling case, and at this point I think it's only a matter of time. Brain Medicine, as an emerging specialty, brings change. That change needs to be measured. EEG might be one such tool.I hope you enjoy today's podcast! And thanks to Sharena Rice, PhD, William M. Sauve, MD, along with Dave, for their guest spots.—OwenAnnouncements: * You can Join The Frontier Psychiatrists LIVE at Psych Congress 2026. Get your tickets now!* You can buy a copy of my IRL in print book on Amazon, Inessential Pharmacology. It's got a lot of good reviews, and one “one star” review, which, in the spirit of transparency, I will excerpt for you:The author has taken a collection of drug leaflets from pharmaceutical companies and woven them together with underwhelming lackluster commentary and memes. He intended to create an engaging reading experience, however, this aim should have been clearly stated, should have been made explicitly clear in the book description. He wanted to have fun writing it and wanted readers to have fun reading it. Now, having missed the return window, I find myself stuck with a book that feels more tedious than enjoyable.Don't miss the return window if you hate my work! Good advice for us all. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit thefrontierpsychiatrists.substack.com/subscribe

July 17, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Eli Lilly acquires AtaiBeckley for up to $3.8B, the largest psychedelic medicine deal yet, gaining an intranasal DMT therapy in Phase 3 for depression Wonder closes $650M Series D at $9B valuation, building a vertically integrated food platform spanning restaurants, delivery, and AI personalization Hemispheric emerges from stealth with $52M and Descartes, a foundation AI model trained on EEG data to diagnose depression, PTSD, and Alzheimer's Today's episode is brought to you by AIIR — a modern communications and experiential agency for health, wellness, fitness, and performance brands. From earned media to events and creator-led campaigns, AIIR helps companies sharpen their story, earn attention, and build trust that compounds. Visit https://aiir.agency to learn more. More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe  Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider  Reach out → insider@fitt.co 

What if excessive gaming isn't the problem...What if it's the symptom?Mark Talaga, founder of the Center for Identity Potential and host of the Hopelessly Gifted podcast, joins EEG pioneer Jay Gunkelman, who has interpreted more than 500,000 brain scans, Dr. Mari Swingle, author of i-Minds: How Cell Phones, Computers, Gaming, and Social Media Are Changing Our Brains, Our Behavior, and the Evolution of Our Species, and host Pete Jansons for a fascinating discussion about giftedness, twice-exceptionality (2e), executive function, anxiety, parenting, education, and why so many bright kids struggle in traditional systems.Drawing from his own journey from the video game industry to becoming a therapist specializing in gifted and neurodivergent individuals, Mark explains why gaming is often a symptom of deeper developmental challenges rather than the root cause itself."If you really want to resolve gaming, don't make it the focus of what you're trying to solve."

Have you considered performing a cochlear implant while your patient is awake? In this episode of the Backtable ENT & Allergy Podcast, Dr. Walter Kutz and Dr. Brandon Isaacson sit down with Dr. Sarah Mowry to explore her protocol for cochlear implants under local anesthesia, an approach especially relevant for older adults concerned about the cognitive risks of general anesthesia. Dr. Mowry shares her criteria for patient selection, preoperative counseling strategies, and how she adapts the OR setup to maximize comfort and communication during awake surgery. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction02:06 - Why to Consider Awake Cochlear Implants05:32 - Indications for Awake CI 08:50 - Local Blocks and Pain Control10:58 - Counseling and Expectations14:40 - Preventing Intraoperative Vertigo and Converting to General Anesthesia 17:17 - Set Up and Communication with Patient 19:14 - Lesser Occipital Nerve Block and Potential Role of Processed EEG26:32 - Pitch Matching for Single-Sided Deafness, CI, and Anxiety Considerations29:00 - Feedback from Patients and Electrode Choice 31:30 - Advice to Surgeons and Closing Remarks --- More about this episode The conversation covers her anesthesia protocol, including lesser occipital and postauricular nerve blocks, minimizing propofol, and using topical 2% lidocaine in sensate areas like the facial recess and epitympanum. Dr. Mowry discusses practical strategies of using warmed irrigation to reduce intraoperative vertigo and contingency plans for conversion to general anesthesia. She discusses electrode considerations and the potential role of processed EEG to titrate anesthesia depth and practical tips for surgeons interested in adopting awake cochlear implantation. Throughout, they highlight the importance of individualized patient care, multidisciplinary teamwork, and the growing role of local anesthesia in otologic surgery. --- Resources Cochlear Implantation Under Local Anesthesia With Conscious Sedation in the Elderly: First 100 Caseshttps://pubmed.ncbi.nlm.nih.gov/32663339/ Cochlear implantation under local anesthesia in 117 cases: patients' subjective experience and outcomeshttps://pubmed.ncbi.nlm.nih.gov/34487218/ --- BackTable ENT & Allergy is the go-to podcast for otolaryngologists, allergists, and head and neck surgeons. Download the free BackTable app to get early access to new episodes, cases, and courses curated by physicians in your specialty. ► https://www.backtable.com/app

Research 1https://doi.org/10.1007/s12013-013-9529-4Research 2https://doi.org/10.1016/j.brs.2018.05.016Research 3https://doi.org/10.1176/appi.ajp.2019.19070720Research 4https://doi.org/10.3988/jcn.2016.12.1.57This episode explores a rapidly growing area of brain science that is transforming how we treat depression, anxiety, insomnia, OCD, and even cognitive decline — without relying on medication. Dr. Yishan welcomes Dr. Elahi, an ABPN board-certified neurologist and founder of NeuroSpa Brain Rejuvenation Center, to discuss Transcranial Magnetic Stimulation (TMS) — a non-invasive technology that uses electromagnetic fields to stimulate specific regions of the brain. We dive into how TMS works, why personalized brain mapping is the key to achieving 90%+ effectiveness, how it compares to traditional medications and ECT, and what the latest research shows about its impact on insomnia, memory disorders, and treatment-resistant depression.

Anxious? Unfocused? Burned out? The answer might be sitting between your ears

Why do neurofeedback practitioners get way better results than the published studies? A listener from the Neurofeedback Exchange Facebook group asked — and the panel spent the hour answering. Joy Lunt's short version: research runs in "the tightest handcuffs you could find." Jay Gunkelman brings the receipts: one artifacted EEG file sent to 15 commercial services came back as pure chaos — and the journal editor called the paper too embarrassing to publish, until Jay threatened to resign. Then the hard-criteria bombshell: standard protocols scored 30%, QEEG-guided hit 60%. Plus the $3M NIMH ADHD study that changed its hypothesis midstream, why BCIA certification doesn't guarantee a good provider, Jay's "the diagnosis world is imaginary," and the kid who lost 80 sessions of progress to one bike crash — and got it back in 24.

In this episode I share something I never thought I would talk about on this microphone: quantum physics. Not the wellness version. The actual physics. The kind that won the 2022 Nobel Prize. I walk you through why some of us feel things in our bodies that other people do not, why midlife makes us more sensitive (not less), how quantum entanglement actually works in plain English, and what happened when I flew to Germany and got my brain measured in a high-density EEG lab. The data is on paper. The lab is real. The results are mine. And I think every midlife woman who has ever been told she is too sensitive deserves to hear this one.   LINKS:  • Leela Quantum:  Get 10% off your first Leela Quantum order with the code NATALIEJILL at checkout  at https://midlifeconversations.com/leela  • Quantum Upgrade: Try Quantum Upgrade completely free for 15 days—no credit card required. Use code NATALIEJILL at checkout on http://quantumupgrade.io/start  • EEG report visuals + summary: https://www.midlifeconversations.com/nataliejillresults/    WHAT YOU WILL LEARN:  • Why classical physics says distance is real and quantum physics says it might not be  • What quantum entanglement actually is, explained two ways  • Why your body is more than chemistry and what that means for midlife  • Why estrogen shifts make us more reactive to EMFs  • What a 30-minute 5G call did to my brain in a 256-channel EEG lab  • What Quantum Upgrade did during the same call  • How Leela Quantum and Quantum Upgrade actually work (it is not streaming, it is not draining your battery, your phone is just a locator)  • Six things you can do with this knowledge starting tonight, zero dollars, no product required   Free Gifts for being a listener of Midlife Conversations! Mastering the Midlife Midsection Guide: https://theflatbellyguide.com/ Age Optimizing and Supplement Guide: https://ageoptimizer.com   Connect with me on social media! Instagram: www.Instagram.com/Nataliejllfit Facebook: www.Facebook.com/Nataliejillfit   For advertising inquiries: https://www.category3.ca/  Disclaimer: Information provided in the Midlife Conversations podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before making any changes to your current regimen.  Information provided in this podcast and the use of any products or services related to this podcast does not create a client-patient relationship between you and the host of Midlife Conversations or you and any doctor or provider interviewed and featured on this show. Information and statements may have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease. Advertising Disclosure: Some episodes of Midlife Conversations may be sponsored by products or services discussed during the show. The host may receive compensation for such advertisements or if you purchase products through affiliate links. Opinions expressed about products or services are those of the host and/or guests and do not necessarily reflect the views of any sponsor. Sponsorship does not imply endorsement of any product or service by healthcare professionals featured on this podcast.

Jay Dhaliwal, founder of Super Patch, joins Mind Pump to break down one of the most unconventional technologies in health and wellness — haptic patches that alleviate pain, improve sleep, boost athletic performance, and more with zero compounds or drugs.  Sal opens up about being deeply skeptical until reviewing the peer-reviewed studies, and the guys walk Jay through the entire origin story — from a passion project to help his mother with MS, to 17 years of research, $40 million of his own money, and 16 published peer-reviewed studies.  They cover the neuroscience of how skin receptors communicate with the brain, what the studies actually show (50% pain reduction, 85% sleep improvement, 5–8% athletic performance gains in D1 athletes), and why half the teams in the NFL are already using the product. Super Patch — https://mindpump.superpatch.com $30 off — no code needed, discount automatically applied at checkout (price drops from $99 to $69) SPONSORS Seed Daily Synbiotic — https://seed.com/mindpump Code: 25MINDPUMP — 25% off first month MAPS 15 BOGO — https://maps15bogo.com Buy 1 get 1 FREE — limited time (all 7 MAPS 15 programs same price) LINKS Mind Pump Store: https://mindpumpstore.com Maps Fitness Products: https://mapsfitnessproducts.com Instagram: @mindpumpmedia 0:00 - Intro 1:48 - What is Super Patch? Sal's skepticism and what changed his mind 5:13 - How this compares to when red light therapy first came on the scene 8:02 - Jay's origin story — his mother's MS and 17 years of research 13:16 - The Loretta Z database — quarter million EEGs and the search for normative neural networks 20:10 - The first breakthrough — identifying the vestibular response network in 2014 24:47 - First proof: comparing his mother's EEG against the normative database 27:43 - From brainwaves to skin receptors — how Braille unlocked the next phase 30:08 - The 2010 discovery of piezo two ion channels and skin sensation science 34:07 - The first product — socks that improved balance and gait by 31% 36:59 - Brain mapping 35 people with the world's leading EEG expert — the impossible result 39:07 - How the pattern in the patch is designed — 1200 iterations of micro tooling 43:52 - 2017 Japan study — skin sensation is permanently imprinted on the sensory cortex 45:46 - From socks to patches — how pain and sleep networks were identified 49:01 - The first clinical study — 50% reduction in perceived pain, 70% reduction in interference scores 53:02 - Sleep study results — 85% of subjects went from bad sleep to good or great sleep 56:51 - Pain relief comparable to 400mg Advil — without the drug 58:38 - Stress patch — 33% reduction in perceived stress, 24% improvement in mental health factors 1:01:35 - D1 athlete study — 5–8% improvement in lower extremity power at University of Arizona 1:03:55 - Half the NFL is already using Super Patch 1:04:17 - Stacking patches — which combinations work best for athletes 1:05:30 - Neuroplasticity — why your baseline gets higher over time with consistent use 1:07:52 - Full product lineup — pain, sleep, stress, focus, libido, immune, Zen flow state & more 1:11:28 - Appetite suppression pilot — 20% improvement in resting metabolic rate 1:13:32 - 5000 MDs in America now recommending Super Patch